TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-194840	Rho GTPase cycle	8.50022927296867e-05	-9.3728323285473	124	14	0.049645390070922	282	8202	1123,64411,23263,58504,1894,57522,4983,84033,101928168,9743,90627,29,9901,84144	CHN1,ARAP3,MCF2L,ARHGAP22,ECT2,SRGAP1,OPHN1,OBSCN,LOC101928168,ARHGAP32,STARD13,ABR,SRGAP3,SYDE2
R-HSA-1474290	Collagen formation	0.000161132699067993	-8.73328231464717	86	11	0.0390070921985816	282	8202	4316,7092,9313,5352,1287,26577,1288,1303,1293,7093,3914	MMP7,TLL1,MMP20,PLOD2,COL4A5,PCOLCE2,COL4A6,COL12A1,COL6A3,TLL2,LAMB3
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.000464769705156519	-7.67396853278545	54	8	0.0283687943262411	282	8202	4316,7092,9313,1287,1288,1293,7093,3914	MMP7,TLL1,MMP20,COL4A5,COL4A6,COL6A3,TLL2,LAMB3
R-HSA-422475	Axon guidance	0.000792654359554588	-7.14012329571591	516	32	0.113475177304965	282	8202	6712,200734,5922,9542,1287,5361,2047,9252,785,5217,9965,1293,6196,5062,1739,57522,7220,776,4233,2247,287,283455,1852,7422,9901,8660,2534,3673,6478,23129,90249,8829	SPTBN2,SPRED2,RASA2,NRG2,COL4A5,PLXNA1,EPHB1,RPS6KA5,CACNB4,PFN2,FGF19,COL6A3,RPS6KA2,PAK2,DLG1,SRGAP1,TRPC1,CACNA1D,MET,FGF2,ANK2,KSR2,DUSP9,VEGFA,SRGAP3,IRS2,FYN,ITGA2,SIAH2,PLXND1,UNC5A,NRP1
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.00126994037551899	-6.66878532802399	7	3	0.0106382978723404	282	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.00126994037551899	-6.66878532802399	7	3	0.0106382978723404	282	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-2214320	Anchoring fibril formation	0.00126994037551899	-6.66878532802399	7	3	0.0106382978723404	282	8202	7092,3914,7093	TLL1,LAMB3,TLL2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.00146963341777782	-6.52274228495212	64	8	0.0283687943262411	282	8202	7092,5352,1287,26577,1288,1303,1293,7093	TLL1,PLOD2,COL4A5,PCOLCE2,COL4A6,COL12A1,COL6A3,TLL2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.00179457279416094	-6.32298828304976	16	4	0.0141843971631206	282	8202	2534,5361,8829,5062	FYN,PLXNA1,NRP1,PAK2
R-HSA-1474244	Extracellular matrix organization	0.00208754630834852	-6.17176591784531	267	19	0.0673758865248227	282	8202	7077,7092,9313,3339,2247,10319,1287,1293,1303,84467,3914,6696,4316,5352,3673,26577,3687,1288,7093	TIMP2,TLL1,MMP20,HSPG2,FGF2,LAMC3,COL4A5,COL6A3,COL12A1,FBN3,LAMB3,SPP1,MMP7,PLOD2,ITGA2,PCOLCE2,ITGAX,COL4A6,TLL2
R-HSA-381119	Unfolded Protein Response (UPR)	0.00267274215709763	-5.92465030846927	86	9	0.0319148936170213	282	8202	58477,440,29927,7095,2137,51726,467,27230,1649	SRPRB,ASNS,SEC61A1,SEC62,EXTL3,DNAJB11,ATF3,SERP1,DDIT3
R-HSA-1474228	Degradation of the extracellular matrix	0.00337850655804516	-5.69032151386244	89	9	0.0319148936170213	282	8202	6696,4316,7077,7092,9313,3339,1303,7093,3914	SPP1,MMP7,TIMP2,TLL1,MMP20,HSPG2,COL12A1,TLL2,LAMB3
R-HSA-977347	Serine biosynthesis	0.00345373858326676	-5.6682979873371	3	2	0.00709219858156028	282	8202	29968,26227	PSAT1,PHGDH
R-HSA-166520	Signalling by NGF	0.00348633763649853	-5.65890348158348	430	26	0.0921985815602837	282	8202	5599,6712,200734,2247,3164,5922,9500,4914,1894,1852,84033,283455,9542,5577,9252,5291,9965,29,84894,8660,57761,2534,6196,23263,5584,4208	MAPK8,SPTBN2,SPRED2,FGF2,NR4A1,RASA2,MAGED1,NTRK1,ECT2,DUSP9,OBSCN,KSR2,NRG2,PRKAR2B,RPS6KA5,PIK3CB,FGF19,ABR,LINGO1,IRS2,TRIB3,FYN,RPS6KA2,MCF2L,PRKCI,MEF2C
R-HSA-352230	Amino acid transport across the plasma membrane	0.00378012327167386	-5.57799865832846	31	5	0.0177304964539007	282	8202	6541,6509,23657,117247,8140	SLC7A1,SLC1A4,SLC7A11,SLC16A10,SLC7A5
R-HSA-193648	NRAGE signals death through JNK	0.00412759881263553	-5.49005944238737	45	6	0.0212765957446809	282	8202	84033,5599,23263,9500,29,1894	OBSCN,MAPK8,MCF2L,MAGED1,ABR,ECT2
R-HSA-196780	Biotin transport and metabolism	0.00540390255236886	-5.22063389154698	11	3	0.0106382978723404	282	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-373753	Nephrin interactions	0.00613209702232625	-5.09421849580057	22	4	0.0141843971631206	282	8202	2534,4868,84063,5291	FYN,NPHS1,KIRREL2,PIK3CB
R-HSA-936837	Ion transport by P-type ATPases	0.00632100743065962	-5.06387667994139	49	6	0.0212765957446809	282	8202	23200,483,23250,10079,27032,9914	ATP11B,ATP1B3,ATP11A,ATP9A,ATP2C1,ATP2C2
R-HSA-202733	Cell surface interactions at the vascular wall	0.00683551132841693	-4.98562400130197	99	9	0.0319148936170213	282	8202	2534,23657,8140,483,857,3687,5291,285,140885	FYN,SLC7A11,SLC7A5,ATP1B3,CAV1,ITGAX,PIK3CB,ANGPT2,SIRPA
R-HSA-193704	p75 NTR receptor-mediated signalling	0.00696040852895197	-4.96751710966989	82	8	0.0283687943262411	282	8202	5599,23263,9500,1894,5584,84033,29,84894	MAPK8,MCF2L,MAGED1,ECT2,PRKCI,OBSCN,ABR,LINGO1
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.0072257680077384	-4.93010175198403	23	4	0.0141843971631206	282	8202	84706,440,29968,26227	GPT2,ASNS,PSAT1,PHGDH
R-HSA-3000157	Laminin interactions	0.0072257680077384	-4.93010175198403	23	4	0.0141843971631206	282	8202	10319,3339,3673,3914	LAMC3,HSPG2,ITGA2,LAMB3
R-HSA-198203	PI3K/AKT activation	0.00777164384689868	-4.85727357367152	101	9	0.0319148936170213	282	8202	8660,57761,2534,2247,3164,4914,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NTRK1,NRG2,FGF19,PIK3CB
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.008202644747637	-4.80329864651398	37	5	0.0177304964539007	282	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.00844074033002916	-4.77468525739307	24	4	0.0141843971631206	282	8202	10335,4842,5140,50940	MRVI1,NOS1,PDE3B,PDE11A
R-HSA-381038	XBP1(S) activates chaperone genes	0.0092594296385425	-4.68211282633093	53	6	0.0212765957446809	282	8202	58477,51726,29927,27230,7095,2137	SRPRB,DNAJB11,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.00935541803257302	-4.67179963478432	104	9	0.0319148936170213	282	8202	8660,57761,2534,2247,3164,9542,9965,5291,7462	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB,LAT2
R-HSA-210991	Basigin interactions	0.00978207860307298	-4.62720328141648	25	4	0.0141843971631206	282	8202	857,483,23657,8140	CAV1,ATP1B3,SLC7A11,SLC7A5
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0102485069026202	-4.58062325204539	39	5	0.0177304964539007	282	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-382551	Transmembrane transport of small molecules	0.0104230717962418	-4.56373348799752	586	31	0.109929078014184	282	8202	285195,6536,10079,1831,64116,27032,9914,2792,9194,9197,5577,6507,23250,1181,7037,6541,23200,6509,23657,6575,7439,8140,3099,261729,7220,55356,483,57101,121601,117247,10057	SLC9A9,SLC6A9,ATP9A,TSC22D3,SLC39A8,ATP2C1,ATP2C2,GNGT1,SLC16A7,SLC33A1,PRKAR2B,SLC1A3,ATP11A,CLCN2,TFRC,SLC7A1,ATP11B,SLC1A4,SLC7A11,SLC20A2,BEST1,SLC7A5,HK2,STEAP2,TRPC1,SLC22A15,ATP1B3,ANO2,ANO4,SLC16A10,ABCC5
R-HSA-74713	IRS activation	0.0109964547423064	-4.5101823542863	5	2	0.00709219858156028	282	8202	8660,2887	IRS2,GRB10
R-HSA-71032	Propionyl-CoA catabolism	0.0109964547423064	-4.5101823542863	5	2	0.00709219858156028	282	8202	5096,5095	PCCB,PCCA
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.0110448981070075	-4.50578666741223	14	3	0.0106382978723404	282	8202	2534,5361,8829	FYN,PLXNA1,NRP1
R-HSA-381070	IRE1alpha activates chaperones	0.0110460633979172	-4.50568116807391	55	6	0.0212765957446809	282	8202	58477,51726,29927,27230,7095,2137	SRPRB,DNAJB11,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-1368082	RORA activates gene expression	0.0128623925447094	-4.35344753200968	27	4	0.0141843971631206	282	8202	6907,9575,79718,406	TBL1X,CLOCK,TBL1XR1,ARNTL
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0139329943021006	-4.2734955608007	42	5	0.0177304964539007	282	8202	10319,3339,2247,3673,3914	LAMC3,HSPG2,FGF2,ITGA2,LAMB3
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.0139329943021006	-4.2734955608007	42	5	0.0177304964539007	282	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0139329943021006	-4.2734955608007	42	5	0.0177304964539007	282	8202	56938,6907,9575,79718,406	ARNTL2,TBL1X,CLOCK,TBL1XR1,ARNTL
R-HSA-399956	CRMPs in Sema3A signaling	0.016152481878991	-4.12568156440282	16	3	0.0106382978723404	282	8202	2534,5361,8829	FYN,PLXNA1,NRP1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0165002364032929	-4.10438057070594	29	4	0.0141843971631206	282	8202	6907,1490,79718,25937	TBL1X,CTGF,TBL1XR1,WWTR1
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0171911401231309	-4.06336113699731	96	8	0.0283687943262411	282	8202	285195,6541,6509,23657,6575,8140,6507,117247	SLC9A9,SLC7A1,SLC1A4,SLC7A11,SLC20A2,SLC7A5,SLC1A3,SLC16A10
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0178480930311135	-4.02585860945438	61	6	0.0212765957446809	282	8202	8660,9542,2534,2247,9965,5291	IRS2,NRG2,FYN,FGF2,FGF19,PIK3CB
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.0178480930311135	-4.02585860945438	61	6	0.0212765957446809	282	8202	84033,5599,23263,9500,29,1894	OBSCN,MAPK8,MCF2L,MAGED1,ABR,ECT2
R-HSA-1266738	Developmental Biology	0.0183868540885705	-3.99611932141757	710	35	0.124113475177305	282	8202	6712,200734,5922,9542,1287,5361,2047,9252,785,5217,9965,1293,6196,5062,1739,57522,7220,776,4233,79718,2247,287,1852,283455,7422,9901,8660,2534,3673,6478,23129,6907,90249,8829,4208	SPTBN2,SPRED2,RASA2,NRG2,COL4A5,PLXNA1,EPHB1,RPS6KA5,CACNB4,PFN2,FGF19,COL6A3,RPS6KA2,PAK2,DLG1,SRGAP1,TRPC1,CACNA1D,MET,TBL1XR1,FGF2,ANK2,DUSP9,KSR2,VEGFA,SRGAP3,IRS2,FYN,ITGA2,SIAH2,PLXND1,TBL1X,UNC5A,NRP1,MEF2C
R-HSA-2990846	SUMOylation	0.0185359973147505	-3.98804063671879	79	7	0.024822695035461	282	8202	165918,7486,80012,9656,10274,205564,286053	RNF168,WRN,PHC3,MDC1,STAG1,SENP5,NSMCE2
R-HSA-109704	PI3K Cascade	0.0185359973147505	-3.98804063671879	79	7	0.024822695035461	282	8202	8660,57761,2247,5140,5291,9965,30849	IRS2,TRIB3,FGF2,PDE3B,PIK3CB,FGF19,PIK3R4
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.0185371294824087	-3.98797955918062	30	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-5654720	PI-3K cascade:FGFR4	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-5654689	PI-3K cascade:FGFR1	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-5654695	PI-3K cascade:FGFR2	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-5654710	PI-3K cascade:FGFR3	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-1257604	PIP3 activates AKT signaling	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0192467407960149	-3.95041354188071	98	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-400253	Circadian Clock	0.0206403046986768	-3.88050957594495	63	6	0.0212765957446809	282	8202	56938,6907,9575,79718,406,4208	ARNTL2,TBL1X,CLOCK,TBL1XR1,ARNTL,MEF2C
R-HSA-199920	CREB phosphorylation	0.0220633668454377	-3.8138366546157	7	2	0.00709219858156028	282	8202	6196,9252	RPS6KA2,RPS6KA5
R-HSA-913709	O-linked glycosylation of mucins	0.0221416570005663	-3.8102945125615	64	6	0.0212765957446809	282	8202	2591,146712,79623,374378,6480,84002	GALNT3,B3GNTL1,GALNT14,GALNT18,ST6GAL1,B3GNT5
R-HSA-418457	cGMP effects	0.0223775857107679	-3.79969545900563	18	3	0.0106382978723404	282	8202	10335,5140,50940	MRVI1,PDE3B,PDE11A
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.0223775857107679	-3.79969545900563	18	3	0.0106382978723404	282	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0230614631774952	-3.76959231526537	32	4	0.0141843971631206	282	8202	23236,5330,2792,1739	PLCB1,PLCB2,GNGT1,DLG1
R-HSA-376176	Signaling by Robo receptor	0.0230614631774952	-3.76959231526537	32	4	0.0141843971631206	282	8202	5217,5062,9901,57522	PFN2,PAK2,SRGAP3,SRGAP1
R-HSA-180292	GAB1 signalosome	0.0238742783684145	-3.73495361847886	102	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-3928664	Ephrin signaling	0.0259127449499405	-3.6530203483005	19	3	0.0106382978723404	282	8202	2534,2047,5062	FYN,EPHB1,PAK2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.0259127449499405	-3.6530203483005	19	3	0.0106382978723404	282	8202	6857,2571,6812	SYT1,GAD1,STXBP1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.0265689315825132	-3.62801273144108	85	7	0.024822695035461	282	8202	8660,9542,2534,2247,3164,9965,5291	IRS2,NRG2,FYN,FGF2,NR4A1,FGF19,PIK3CB
R-HSA-373755	Semaphorin interactions	0.0270828436483437	-3.6088548272804	67	6	0.0212765957446809	282	8202	23129,2534,5361,8829,4233,5062	PLXND1,FYN,PLXNA1,NRP1,MET,PAK2
R-HSA-164944	Nef and signal transduction	0.0287576914539246	-3.54885001868607	8	2	0.00709219858156028	282	8202	2534,5062	FYN,PAK2
R-HSA-400451	Free fatty acids regulate insulin secretion	0.0287576914539246	-3.54885001868607	8	2	0.00709219858156028	282	8202	23236,5330	PLCB1,PLCB2
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.0287576914539246	-3.54885001868607	8	2	0.00709219858156028	282	8202	23236,5330	PLCB1,PLCB2
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0297290935776253	-3.51562913091235	20	3	0.0106382978723404	282	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-109582	Hemostasis	0.0307831020811378	-3.48078937328645	515	26	0.0921985815602837	282	8202	7273,2792,2625,10335,4842,5577,857,7422,80005,5140,5291,140885,50940,10019,2534,23657,2624,3673,8140,483,3687,11343,1608,285,4602,7277	TTN,GNGT1,GATA3,MRVI1,NOS1,PRKAR2B,CAV1,VEGFA,DOCK5,PDE3B,PIK3CB,SIRPA,PDE11A,SH2B3,FYN,SLC7A11,GATA2,ITGA2,SLC7A5,ATP1B3,ITGAX,MGLL,DGKG,ANGPT2,MYB,TUBA4A
R-HSA-500657	Presynaptic function of Kainate receptors	0.0338248869464061	-3.38655844723963	21	3	0.0106382978723404	282	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.0338248869464061	-3.38655844723963	21	3	0.0106382978723404	282	8202	2534,9252,5062	FYN,RPS6KA5,PAK2
R-HSA-198753	ERK/MAPK targets	0.0338248869464061	-3.38655844723963	21	3	0.0106382978723404	282	8202	6196,9252,4208	RPS6KA2,RPS6KA5,MEF2C
R-HSA-140180	COX reactions	0.0343818580829488	-3.37022623502685	1	1	0.00354609929078014	282	8202	5742	PTGS1
R-HSA-2243919	Crosslinking of collagen fibrils	0.0361469149211413	-3.32016367506638	9	2	0.00709219858156028	282	8202	7092,7093	TLL1,TLL2
R-HSA-428543	Inactivation of Cdc42 and Rac	0.0361469149211413	-3.32016367506638	9	2	0.00709219858156028	282	8202	9901,57522	SRGAP3,SRGAP1
R-HSA-447041	CHL1 interactions	0.0361469149211413	-3.32016367506638	9	2	0.00709219858156028	282	8202	8829,3673	NRP1,ITGA2
R-HSA-419037	NCAM1 interactions	0.0370949143536121	-3.29427539818245	37	4	0.0141843971631206	282	8202	1287,776,785,1293	COL4A5,CACNA1D,CACNB4,COL6A3
R-HSA-176187	Activation of ATR in response to replication stress	0.0370949143536121	-3.29427539818245	37	4	0.0141843971631206	282	8202	5984,545,4171,3364	RFC4,ATR,MCM2,HUS1
R-HSA-983712	Ion channel transport	0.0402217240661005	-3.21334802966623	198	12	0.0425531914893617	282	8202	23200,10079,1831,27032,7439,9914,7220,57101,483,23250,121601,1181	ATP11B,ATP9A,TSC22D3,ATP2C1,BEST1,ATP2C2,TRPC1,ANO2,ATP1B3,ATP11A,ANO4,CLCN2
R-HSA-375165	NCAM signaling for neurite out-growth	0.04074114557984	-3.20051674928967	266	15	0.0531914893617021	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,1287,776,9252,785,9965,1293	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,COL4A5,CACNA1D,RPS6KA5,CACNB4,FGF19,COL6A3
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.0413073349346338	-3.18671519346155	74	6	0.0212765957446809	282	8202	165918,7486,80012,9656,10274,286053	RNF168,WRN,PHC3,MDC1,STAG1,NSMCE2
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.0413073349346338	-3.18671519346155	74	6	0.0212765957446809	282	8202	165918,7486,80012,9656,10274,286053	RNF168,WRN,PHC3,MDC1,STAG1,NSMCE2
R-HSA-74749	Signal attenuation	0.0441756944845954	-3.1195805396867	10	2	0.00709219858156028	282	8202	8660,2887	IRS2,GRB10
R-HSA-418886	Netrin mediated repulsion signals	0.0441756944845954	-3.1195805396867	10	2	0.00709219858156028	282	8202	2534,90249	FYN,UNC5A
R-HSA-399997	Acetylcholine regulates insulin secretion	0.0441756944845954	-3.1195805396867	10	2	0.00709219858156028	282	8202	23236,5330	PLCB1,PLCB2
R-HSA-418889	Ligand-independent caspase activation via DCC	0.0441756944845954	-3.1195805396867	10	2	0.00709219858156028	282	8202	90249,9500	UNC5A,MAGED1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.0477578170161284	-3.0416125183099	24	3	0.0106382978723404	282	8202	6196,9252,4208	RPS6KA2,RPS6KA5,MEF2C
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0477578170161284	-3.0416125183099	24	3	0.0106382978723404	282	8202	6507,6857,6812	SLC1A3,SYT1,STXBP1
R-HSA-373760	L1CAM interactions	0.0491036917728308	-3.01382105815218	97	7	0.024822695035461	282	8202	6712,6196,8829,9252,287,3673,1739	SPTBN2,RPS6KA2,NRP1,RPS6KA5,ANK2,ITGA2,DLG1
R-HSA-5693607	Processing of DNA double-strand break ends	0.0491036917728308	-3.01382105815218	97	7	0.024822695035461	282	8202	5984,165918,545,7486,9656,11073,3364	RFC4,RNF168,ATR,WRN,MDC1,TOPBP1,HUS1
R-HSA-380994	ATF4 activates genes	0.0529363268001702	-2.9386654687957	25	3	0.0106382978723404	282	8202	467,440,1649	ATF3,ASNS,DDIT3
R-HSA-373752	Netrin-1 signaling	0.0551093324265951	-2.89843620463169	42	4	0.0141843971631206	282	8202	7220,2534,90249,6478	TRPC1,FYN,UNC5A,SIAH2
R-HSA-422356	Regulation of insulin secretion	0.056674928210617	-2.87042334927453	80	6	0.0212765957446809	282	8202	5577,776,6812,23236,5330,2792	PRKAR2B,CACNA1D,STXBP1,PLCB1,PLCB2,GNGT1
R-HSA-112315	Transmission across Chemical Synapses	0.0581352845919718	-2.84498249150979	210	12	0.0425531914893617	282	8202	217,6196,84254,2792,1739,6507,6857,2571,785,6812,5330,23236	ALDH2,RPS6KA2,CAMKK1,GNGT1,DLG1,SLC1A3,SYT1,GAD1,CACNB4,STXBP1,PLCB2,PLCB1
R-HSA-74751	Insulin receptor signalling cascade	0.0587993604380662	-2.83362430104035	280	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,2247,5922,30849,1852,283455,9542,2887,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,GRB10,PDE3B,PIK3CB,FGF19
R-HSA-2428924	IGF1R signaling cascade	0.060270115438585	-2.80891889613171	281	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,3480,2247,5922,30849,1852,283455,9542,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,IGF1R,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,PDE3B,PIK3CB,FGF19
R-HSA-2428928	IRS-related events triggered by IGF1R	0.060270115438585	-2.80891889613171	281	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,3480,2247,5922,30849,1852,283455,9542,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,IGF1R,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,PDE3B,PIK3CB,FGF19
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.060270115438585	-2.80891889613171	281	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,3480,2247,5922,30849,1852,283455,9542,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,IGF1R,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,PDE3B,PIK3CB,FGF19
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.061569116528012	-2.78759488922788	212	12	0.0425531914893617	282	8202	57761,5096,1490,79718,5095,56895,622,25937,406,6907,9575,23175	TRIB3,PCCB,CTGF,TBL1XR1,PCCA,AGPAT4,BDH1,WWTR1,ARNTL,TBL1X,CLOCK,LPIN1
R-HSA-389359	CD28 dependent Vav1 pathway	0.0619452181711472	-2.7815048624068	12	2	0.00709219858156028	282	8202	2534,5062	FYN,PAK2
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.0633963088376149	-2.75834963946071	355	18	0.0638297872340425	282	8202	6712,200734,2247,3164,5922,4914,1852,283455,9542,5577,9252,5291,9965,8660,57761,6196,2534,4208	SPTBN2,SPRED2,FGF2,NR4A1,RASA2,NTRK1,DUSP9,KSR2,NRG2,PRKAR2B,RPS6KA5,PIK3CB,FGF19,IRS2,TRIB3,RPS6KA2,FYN,MEF2C
R-HSA-5173105	O-linked glycosylation	0.0638911896936838	-2.75057380357265	103	7	0.024822695035461	282	8202	23145,2591,146712,79623,374378,6480,84002	SSPO,GALNT3,B3GNTL1,GALNT14,GALNT18,ST6GAL1,B3GNT5
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0640619227856854	-2.74790511986467	27	3	0.0106382978723404	282	8202	23007,23236,5330	PLCH1,PLCB1,PLCB2
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-380612	Metabolism of serotonin	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	217	ALDH2
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-888568	GABA synthesis	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	2571	GAD1
R-HSA-165160	PDE3B signalling	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	5140	PDE3B
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	217	ALDH2
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-187042	TRKA activation by NGF	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	4914	NTRK1
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.0675856522552466	-2.69435956320519	2	1	0.00354609929078014	282	8202	4129	MAOB
R-HSA-5668914	Diseases of metabolism	0.0678154339749126	-2.69096547019381	45	4	0.0141843971631206	282	8202	5096,2992,5095,56922	PCCB,GYG1,PCCA,MCCC1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.069996183200995	-2.65931456411943	28	3	0.0106382978723404	282	8202	57761,857,5062	TRIB3,CAV1,PAK2
R-HSA-381042	PERK regulates gene expression	0.069996183200995	-2.65931456411943	28	3	0.0106382978723404	282	8202	467,440,1649	ATF3,ASNS,DDIT3
R-HSA-425407	SLC-mediated transmembrane transport	0.0709291941095304	-2.64607316560443	264	14	0.049645390070922	282	8202	285195,6541,6536,6509,23657,64116,6575,8140,9194,3099,9197,55356,6507,117247	SLC9A9,SLC7A1,SLC6A9,SLC1A4,SLC7A11,SLC39A8,SLC20A2,SLC7A5,SLC16A7,HK2,SLC33A1,SLC22A15,SLC1A3,SLC16A10
R-HSA-5210891	Uptake and function of anthrax toxins	0.0715895389292289	-2.63680632003019	13	2	0.00709219858156028	282	8202	118429,84168	ANTXR2,ANTXR1
R-HSA-75892	Platelet Adhesion to exposed collagen	0.0715895389292289	-2.63680632003019	13	2	0.00709219858156028	282	8202	2534,3673	FYN,ITGA2
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.0720861202821422	-2.629893759712	65	5	0.0177304964539007	282	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-112316	Neuronal System	0.0729446328828025	-2.61805457926548	289	15	0.0531914893617021	282	8202	217,6196,84254,2792,3755,1739,6507,6857,2571,785,23236,6812,3749,5330,8514	ALDH2,RPS6KA2,CAMKK1,GNGT1,KCNG1,DLG1,SLC1A3,SYT1,GAD1,CACNB4,PLCB1,STXBP1,KCNC4,PLCB2,KCNAB2
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0761687924476714	-2.57480344810802	29	3	0.0106382978723404	282	8202	118429,6857,84168	ANTXR2,SYT1,ANTXR1
R-HSA-1500931	Cell-Cell communication	0.0816547217453044	-2.5052556321464	131	8	0.0283687943262411	282	8202	5599,2534,84063,5584,4868,5291,140885,3914	MAPK8,FYN,KIRREL2,PRKCI,NPHS1,PIK3CB,SIRPA,LAMB3
R-HSA-190322	FGFR4 ligand binding and activation	0.0816803123985037	-2.50494228046967	14	2	0.00709219858156028	282	8202	2247,9965	FGF2,FGF19
R-HSA-194138	Signaling by VEGF	0.0847805272291109	-2.46768939428587	320	16	0.0567375886524823	282	8202	6712,200734,2247,5922,1852,283455,9542,857,7422,9965,5291,8660,57761,2534,5062,8829	SPTBN2,SPRED2,FGF2,RASA2,DUSP9,KSR2,NRG2,CAV1,VEGFA,FGF19,PIK3CB,IRS2,TRIB3,FYN,PAK2,NRP1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0853999341691962	-2.46040994904041	89	6	0.0212765957446809	282	8202	5599,6196,9252,170506,4208,30849	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C,PIK3R4
R-HSA-186797	Signaling by PDGF	0.0856477201537615	-2.45751267273602	345	17	0.0602836879432624	282	8202	6712,200734,2247,3164,5922,1852,283455,9542,1287,5577,9965,5291,1293,8660,6696,57761,2534	SPTBN2,SPRED2,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,COL4A5,PRKAR2B,FGF19,PIK3CB,COL6A3,IRS2,SPP1,TRIB3,FYN
R-HSA-1989781	PPARA activates gene expression	0.0906500593613895	-2.40074868693991	112	7	0.024822695035461	282	8202	57761,6907,9575,1490,79718,25937,406	TRIB3,TBL1X,CLOCK,CTGF,TBL1XR1,WWTR1,ARNTL
R-HSA-112310	Neurotransmitter Release Cycle	0.0920271220856914	-2.38567194010038	50	4	0.0141843971631206	282	8202	6507,6857,2571,6812	SLC1A3,SYT1,GAD1,STXBP1
R-HSA-975577	N-Glycan antennae elongation	0.0921756875489145	-2.38405887572062	15	2	0.00709219858156028	282	8202	6480,4249	ST6GAL1,MGAT5
R-HSA-112399	IRS-mediated signalling	0.0958393672142635	-2.34508174715909	277	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,5922,30849,1852,283455,9542,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,PDE3B,PIK3CB,FGF19
R-HSA-389356	CD28 co-stimulation	0.0960407971812132	-2.34298220715111	32	3	0.0106382978723404	282	8202	57761,2534,5062	TRIB3,FYN,PAK2
R-HSA-397795	G-protein beta:gamma signalling	0.0973043531372802	-2.32991155145611	51	4	0.0141843971631206	282	8202	23236,5330,5291,2792	PLCB1,PLCB2,PIK3CB,GNGT1
R-HSA-77108	Utilization of Ketone Bodies	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	622	BDH1
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	10644	IGF2BP2
R-HSA-198745	Signalling to STAT3	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	4914	NTRK1
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-5357572	Lysosomal glycogen catabolism	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	6857	SYT1
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	2736	GLI2
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	6857	SYT1
R-HSA-1307965	betaKlotho-mediated ligand binding	0.0996516090931771	-2.30607508500586	3	1	0.00354609929078014	282	8202	9965	FGF19
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.100784239449674	-2.29477329023547	115	7	0.024822695035461	282	8202	57761,6907,9575,1490,79718,25937,406	TRIB3,TBL1X,CLOCK,CTGF,TBL1XR1,WWTR1,ARNTL
R-HSA-74752	Signaling by Insulin receptor	0.10119247483219	-2.29073088425927	304	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,2247,5922,30849,1852,283455,9542,2887,5140,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,RASA2,PIK3R4,DUSP9,KSR2,NRG2,GRB10,PDE3B,PIK3CB,FGF19
R-HSA-1433559	Regulation of KIT signaling	0.103036145499936	-2.2726754251292	16	2	0.00709219858156028	282	8202	10019,2534	SH2B3,FYN
R-HSA-1433557	Signaling by SCF-KIT	0.107556341520844	-2.22974046153997	307	15	0.0531914893617021	282	8202	8660,10019,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,2887,9965,5291	IRS2,SH2B3,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,GRB10,FGF19,PIK3CB
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.114224389570713	-2.16959043564239	17	2	0.00709219858156028	282	8202	5096,5095	PCCB,PCCA
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.114224389570713	-2.16959043564239	17	2	0.00709219858156028	282	8202	6857,6812	SYT1,STXBP1
R-HSA-597592	Post-translational protein modification	0.11510719089608	-2.16189149000093	411	19	0.0673758865248227	282	8202	23145,10274,6480,56648,7486,9656,79623,84002,2591,10195,6184,80012,286053,165918,89978,146712,374378,4249,205564	SSPO,STAG1,ST6GAL1,EIF5A2,WRN,MDC1,GALNT14,B3GNT5,GALNT3,ALG3,RPN1,PHC3,NSMCE2,RNF168,DPH6,B3GNTL1,GALNT18,MGAT5,SENP5
R-HSA-416482	G alpha (12/13) signalling events	0.115132737566784	-2.16166957653023	75	5	0.0177304964539007	282	8202	84033,23263,2792,29,1894	OBSCN,MCF2L,GNGT1,ABR,ECT2
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.118692692563203	-2.13121754149235	312	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,2247,5922,5062,1852,283455,9542,857,7422,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,RASA2,PAK2,DUSP9,KSR2,NRG2,CAV1,VEGFA,FGF19,PIK3CB
R-HSA-2672351	Stimuli-sensing channels	0.125121592021719	-2.07846927830733	99	6	0.0212765957446809	282	8202	7220,57101,121601,1181,1831,7439	TRPC1,ANO2,ANO4,CLCN2,TSC22D3,BEST1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.125705240050708	-2.07381547729612	18	2	0.00709219858156028	282	8202	6857,6812	SYT1,STXBP1
R-HSA-912631	Regulation of signaling by CBL	0.125705240050708	-2.07381547729612	18	2	0.00709219858156028	282	8202	2534,5291	FYN,PIK3CB
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.125705240050708	-2.07381547729612	18	2	0.00709219858156028	282	8202	6857,6812	SYT1,STXBP1
R-HSA-210993	Tie2 Signaling	0.125705240050708	-2.07381547729612	18	2	0.00709219858156028	282	8202	5291,285	PIK3CB,ANGPT2
R-HSA-418346	Platelet homeostasis	0.130001444171887	-2.04020971957374	78	5	0.0177304964539007	282	8202	10335,4842,5140,2792,50940	MRVI1,NOS1,PDE3B,GNGT1,PDE11A
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.130033219578064	-2.03996532595424	342	16	0.0567375886524823	282	8202	5599,6712,200734,2247,3164,5922,1852,283455,9542,5291,9965,7462,8660,57761,2534,5062	MAPK8,SPTBN2,SPRED2,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PIK3CB,FGF19,LAT2,IRS2,TRIB3,FYN,PAK2
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	56648	EIF5A2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	6507	SLC1A3
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	5366	PMAIP1
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	8829	NRP1
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	9194	SLC16A7
R-HSA-140179	Amine Oxidase reactions	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	4129	MAOB
R-HSA-165158	Activation of AKT2	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	57761	TRIB3
R-HSA-390650	Histamine receptors	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	3269	HRH1
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.130618586313608	-2.03547375746002	4	1	0.00354609929078014	282	8202	6507	SLC1A3
R-HSA-416700	Other semaphorin interactions	0.137445533591172	-1.98452755968843	19	2	0.00709219858156028	282	8202	23129,5361	PLXND1,PLXNA1
R-HSA-1852241	Organelle biogenesis and maintenance	0.140390712652815	-1.96332593877485	321	15	0.0531914893617021	282	8202	56945,85476,80321,79718,50807,55764,60412,5577,6907,80254,27031,11222,57129,7277,4208	MRPS22,GFM1,CEP70,TBL1XR1,ASAP1,IFT122,EXOC4,PRKAR2B,TBL1X,CEP63,NPHP3,MRPL3,MRPL47,TUBA4A,MEF2C
R-HSA-69236	G1 Phase	0.141137890120379	-1.95801792236362	38	3	0.0106382978723404	282	8202	902,7029,1021	CCNH,TFDP2,CDK6
R-HSA-1442490	Collagen degradation	0.141137890120379	-1.95801792236362	38	3	0.0106382978723404	282	8202	4316,9313,1303	MMP7,MMP20,COL12A1
R-HSA-69231	Cyclin D associated events in G1	0.141137890120379	-1.95801792236362	38	3	0.0106382978723404	282	8202	902,7029,1021	CCNH,TFDP2,CDK6
R-HSA-194315	Signaling by Rho GTPases	0.14392563235058	-1.9384585548181	399	18	0.0638297872340425	282	8202	64411,58504,1894,4983,84033,9743,5585,5217,9901,29,84144,1123,23263,5062,57522,101928168,90627,114793	ARAP3,ARHGAP22,ECT2,OPHN1,OBSCN,ARHGAP32,PKN1,PFN2,SRGAP3,ABR,SYDE2,CHN1,MCF2L,PAK2,SRGAP1,LOC101928168,STARD13,FMNL2
R-HSA-2871796	FCERI mediated MAPK activation	0.146557732654947	-1.92033584859801	248	12	0.0425531914893617	282	8202	8660,5599,6712,200734,2534,2247,5922,5062,1852,283455,9542,9965	IRS2,MAPK8,SPTBN2,SPRED2,FYN,FGF2,RASA2,PAK2,DUSP9,KSR2,NRG2,FGF19
R-HSA-2028269	Signaling by Hippo	0.149414026925575	-1.90103412229993	20	2	0.00709219858156028	282	8202	51421,25937	AMOTL2,WWTR1
R-HSA-3000170	Syndecan interactions	0.149414026925575	-1.90103412229993	20	2	0.00709219858156028	282	8202	2247,3673	FGF2,ITGA2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.149414026925575	-1.90103412229993	20	2	0.00709219858156028	282	8202	857,11343	CAV1,MGLL
R-HSA-450294	MAP kinase activation in TLR cascade	0.150642231953996	-1.89284757826666	60	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-69481	G2/M Checkpoints	0.152602447725832	-1.87991912011735	105	6	0.0212765957446809	282	8202	5984,165918,545,9656,4171,3364	RFC4,RNF168,ATR,MDC1,MCM2,HUS1
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.155684559042282	-1.85992337627204	129	7	0.024822695035461	282	8202	5984,165918,545,7486,9656,11073,3364	RFC4,RNF168,ATR,WRN,MDC1,TOPBP1,HUS1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	10057	ABCC5
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	6575	SLC20A2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	9542	NRG2
R-HSA-187024	NGF-independant TRKA activation	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	4914	NTRK1
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	857	CAV1
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	27031	NPHP3
R-HSA-426048	Arachidonate production from DAG	0.160524119206845	-1.82931107227023	5	1	0.00354609929078014	282	8202	11343	MGLL
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.161581304821969	-1.82274682757038	21	2	0.00709219858156028	282	8202	57761,2534	TRIB3,FYN
R-HSA-5620916	VxPx cargo-targeting to cilium	0.161581304821969	-1.82274682757038	21	2	0.00709219858156028	282	8202	50807,60412	ASAP1,EXOC4
R-HSA-111885	Opioid Signalling	0.162153469172159	-1.81921205162475	84	5	0.0177304964539007	282	8202	5577,5144,23236,5330,2792	PRKAR2B,PDE4D,PLCB1,PLCB2,GNGT1
R-HSA-163685	Integration of energy metabolism	0.16231705764493	-1.81820371050831	107	6	0.0212765957446809	282	8202	5577,776,6812,23236,5330,2792	PRKAR2B,CACNA1D,STXBP1,PLCB1,PLCB2,GNGT1
R-HSA-392499	Metabolism of proteins	0.166796368324381	-1.79098156193012	943	38	0.134751773049645	282	8202	23145,3339,6480,23621,7095,3800,51726,9656,84002,58477,6184,440,89978,146712,374378,4249,205564,7277,8893,10274,1974,56648,2137,467,7486,79623,27230,10195,2591,6165,80012,29927,286053,60412,1803,6747,165918,1649	SSPO,HSPG2,ST6GAL1,BACE1,SEC62,KIF5C,DNAJB11,MDC1,B3GNT5,SRPRB,RPN1,ASNS,DPH6,B3GNTL1,GALNT18,MGAT5,SENP5,TUBA4A,EIF2B5,STAG1,EIF4A2,EIF5A2,EXTL3,ATF3,WRN,GALNT14,SERP1,ALG3,GALNT3,RPL35A,PHC3,SEC61A1,NSMCE2,EXOC4,DPP4,SSR3,RNF168,DDIT3
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.167801064257487	-1.78497614255266	85	5	0.0177304964539007	282	8202	5599,6196,9252,170506,4208	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.167801064257487	-1.78497614255266	85	5	0.0177304964539007	282	8202	5599,6196,9252,170506,4208	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.170479639179233	-1.76913940769312	63	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.170479639179233	-1.76913940769312	63	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-203765	eNOS activation and regulation	0.173919692029086	-1.74916162637273	22	2	0.00709219858156028	282	8202	857,2644	CAV1,GCHFR
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.173919692029086	-1.74916162637273	22	2	0.00709219858156028	282	8202	6480,4249	ST6GAL1,MGAT5
R-HSA-202131	Metabolism of nitric oxide	0.173919692029086	-1.74916162637273	22	2	0.00709219858156028	282	8202	857,2644	CAV1,GCHFR
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.174418916874572	-1.74629530507202	42	3	0.0106382978723404	282	8202	6907,79718,4208	TBL1X,TBL1XR1,MEF2C
R-HSA-170984	ARMS-mediated activation	0.175331522726838	-1.74107668161887	232	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-187706	Signalling to p38 via RIT and RIN	0.175331522726838	-1.74107668161887	232	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-170968	Frs2-mediated activation	0.178777573542823	-1.72161285172227	233	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654716	Downstream signaling of activated FGFR4	0.180526286094853	-1.71187888247776	310	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5654687	Downstream signaling of activated FGFR1	0.180526286094853	-1.71187888247776	310	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5654708	Downstream signaling of activated FGFR3	0.180526286094853	-1.71187888247776	310	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5654696	Downstream signaling of activated FGFR2	0.180526286094853	-1.71187888247776	310	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-177929	Signaling by EGFR	0.181105231613238	-1.70867702652969	336	15	0.0531914893617021	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291,5796	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB,PTPRK
R-HSA-5693538	Homology Directed Repair	0.182718012897289	-1.69981122769792	135	7	0.024822695035461	282	8202	5984,165918,545,7486,9656,11073,3364	RFC4,RNF168,ATR,WRN,MDC1,TOPBP1,HUS1
R-HSA-1296072	Voltage gated Potassium channels	0.183061185582548	-1.69793483457675	43	3	0.0106382978723404	282	8202	3749,3755,8514	KCNC4,KCNG1,KCNAB2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.183061185582548	-1.69793483457675	43	3	0.0106382978723404	282	8202	6498,7029,25937	SKIL,TFDP2,WWTR1
R-HSA-169893	Prolonged ERK activation events	0.185765547513021	-1.68326989760562	235	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-70895	Branched-chain amino acid catabolism	0.186403169134892	-1.67984337507854	23	2	0.00709219858156028	282	8202	594,56922	BCKDHB,MCCC1
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.186403169134892	-1.67984337507854	23	2	0.00709219858156028	282	8202	2247,9965	FGF2,FGF19
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.186403169134892	-1.67984337507854	23	2	0.00709219858156028	282	8202	6857,6812	SYT1,STXBP1
R-HSA-4839726	Chromatin organization	0.187739409654447	-1.67270039656291	261	12	0.0425531914893617	282	8202	80853,8464,7403,55167,8607,79718,84159,6907,9575,55689,86,2122	KDM7A,SUPT3H,KDM6A,MSL2,RUVBL1,TBL1XR1,ARID5B,TBL1X,CLOCK,YEATS2,ACTL6A,MECOM
R-HSA-3247509	Chromatin modifying enzymes	0.187739409654447	-1.67270039656291	261	12	0.0425531914893617	282	8202	80853,8464,7403,55167,8607,79718,84159,6907,9575,55689,86,2122	KDM7A,SUPT3H,KDM6A,MSL2,RUVBL1,TBL1XR1,ARID5B,TBL1X,CLOCK,YEATS2,ACTL6A,MECOM
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	11343	MGLL
R-HSA-190370	FGFR1b ligand binding and activation	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-171319	Telomere Extension By Telomerase	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	8607	RUVBL1
R-HSA-77111	Synthesis of Ketone Bodies	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	622	BDH1
R-HSA-187015	Activation of TRKA receptors	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	4914	NTRK1
R-HSA-3065679	SUMO is proteolytically processed	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	205564	SENP5
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	84254	CAMKK1
R-HSA-444257	RSK activation	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	6196	RPS6KA2
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.189404465477164	-1.66387052154313	6	1	0.00354609929078014	282	8202	22943	DKK1
R-HSA-5654741	Signaling by FGFR3	0.18966679393017	-1.66248646253906	313	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5654743	Signaling by FGFR4	0.18966679393017	-1.66248646253906	313	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5654736	Signaling by FGFR1	0.192762423256616	-1.64629681592248	314	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5693532	DNA Double-Strand Break Repair	0.194178326692002	-1.63897833238079	162	8	0.0283687943262411	282	8202	5599,5984,11073,545,165918,7486,9656,3364	MAPK8,RFC4,TOPBP1,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-912526	Interleukin receptor SHC signaling	0.196481198439195	-1.62718853449394	238	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,5291,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,PIK3CB,FGF19
R-HSA-216083	Integrin cell surface interactions	0.198238568440318	-1.61828408247363	67	4	0.0141843971631206	282	8202	6696,3687,3339,3673	SPP1,ITGAX,HSPG2,ITGA2
R-HSA-5654738	Signaling by FGFR2	0.199025361897215	-1.61432301565861	316	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-167044	Signalling to RAS	0.200113733117418	-1.60886940847602	239	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-190236	Signaling by FGFR	0.202192146811698	-1.59853681186564	317	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.207467166780599	-1.5727821842141	241	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,7422,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,VEGFA,FGF19
R-HSA-112043	PLC beta mediated events	0.209624244849209	-1.56243866123424	46	3	0.0106382978723404	282	8202	5577,23236,5330	PRKAR2B,PLCB1,PLCB2
R-HSA-1483249	Inositol phosphate metabolism	0.209624244849209	-1.56243866123424	46	3	0.0106382978723404	282	8202	23007,23236,5330	PLCH1,PLCB1,PLCB2
R-HSA-114452	Activation of BH3-only proteins	0.211709115121696	-1.55254204498176	25	2	0.00709219858156028	282	8202	5599,5366	MAPK8,PMAIP1
R-HSA-1227986	Signaling by ERBB2	0.211830495671694	-1.5519688728381	320	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-447038	NrCAM interactions	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	1739	DLG1
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-74182	Ketone body metabolism	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	622	BDH1
R-HSA-448706	Interleukin-1 processing	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	3606	IL18
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.217294648584497	-1.52650101887759	7	1	0.00354609929078014	282	8202	131870	NUDT16
R-HSA-186763	Downstream signal transduction	0.218368220850406	-1.52157255462555	322	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,FGF19,PIK3CB
R-HSA-112040	G-protein mediated events	0.218663045121513	-1.52022334078761	47	3	0.0106382978723404	282	8202	5577,23236,5330	PRKAR2B,PLCB1,PLCB2
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.221210745144565	-1.50863943391084	168	8	0.0283687943262411	282	8202	8660,57761,2534,2247,3164,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NRG2,FGF19,PIK3CB
R-HSA-451927	Interleukin-2 signaling	0.22251468295991	-1.50276218872209	245	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,5291,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,PIK3CB,FGF19
R-HSA-264876	Insulin processing	0.224487117541637	-1.49393695633432	26	2	0.00709219858156028	282	8202	3800,60412	KIF5C,EXOC4
R-HSA-2029485	Role of phospholipids in phagocytosis	0.224487117541637	-1.49393695633432	26	2	0.00709219858156028	282	8202	5337,5291	PLD1,PIK3CB
R-HSA-187687	Signalling to ERKs	0.226344765432777	-1.48569593135487	246	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,4914,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,NTRK1,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.227780589295384	-1.47937244101405	48	3	0.0106382978723404	282	8202	5577,2247,9965	PRKAR2B,FGF2,FGF19
R-HSA-3214842	HDMs demethylate histones	0.227780589295384	-1.47937244101405	48	3	0.0106382978723404	282	8202	80853,7403,84159	KDM7A,KDM6A,ARID5B
R-HSA-2424491	DAP12 signaling	0.228337134256461	-1.47693208314791	325	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,PIK3CB,FGF19
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.234671267813321	-1.44956960452539	72	4	0.0141843971631206	282	8202	6498,7029,7048,25937	SKIL,TFDP2,TGFBR2,WWTR1
R-HSA-1483257	Phospholipid metabolism	0.236794527766923	-1.44056248533169	146	7	0.024822695035461	282	8202	5337,11343,5291,5305,56895,23175,30849	PLD1,MGLL,PIK3CB,PIP4K2A,AGPAT4,LPIN1,PIK3R4
R-HSA-72766	Translation	0.236794527766923	-1.44056248533169	146	7	0.024822695035461	282	8202	58477,6747,6184,6165,8893,29927,1974	SRPRB,SSR3,RPN1,RPL35A,EIF2B5,SEC61A1,EIF4A2
R-HSA-180024	DARPP-32 events	0.237321133118234	-1.43834106296027	27	2	0.00709219858156028	282	8202	5577,5144	PRKAR2B,PDE4D
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.237321133118234	-1.43834106296027	27	2	0.00709219858156028	282	8202	90249,9500	UNC5A,MAGED1
R-HSA-114508	Effects of PIP2 hydrolysis	0.237321133118234	-1.43834106296027	27	2	0.00709219858156028	282	8202	11343,1608	MGLL,DGKG
R-HSA-437239	Recycling pathway of L1	0.237321133118234	-1.43834106296027	27	2	0.00709219858156028	282	8202	6196,9252	RPS6KA2,RPS6KA5
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.241587047014976	-1.42052542770733	198	9	0.0319148936170213	282	8202	8660,57761,2534,2247,3164,7220,9542,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,TRPC1,NRG2,FGF19,PIK3CB
R-HSA-380287	Centrosome maturation	0.242147765029682	-1.41820713986914	73	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.242147765029682	-1.41820713986914	73	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	4233	MET
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	5366	PMAIP1
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	7422	VEGFA
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	8309	ACOX2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	57761	TRIB3
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	217	ALDH2
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	89978	DPH6
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-194313	VEGF ligand-receptor interactions	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	7422	VEGFA
R-HSA-72731	Recycling of eIF2:GDP	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	8893	EIF2B5
R-HSA-1483148	Synthesis of PG	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	5337	PLD1
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.244228499601409	-1.40965101813067	8	1	0.00354609929078014	282	8202	84894	LINGO1
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.250192283115292	-1.38552552428952	28	2	0.00709219858156028	282	8202	2534,5062	FYN,PAK2
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.250192283115292	-1.38552552428952	28	2	0.00709219858156028	282	8202	776,2792	CACNA1D,GNGT1
R-HSA-1483166	Synthesis of PA	0.250192283115292	-1.38552552428952	28	2	0.00709219858156028	282	8202	5337,56895	PLD1,AGPAT4
R-HSA-1483255	PI Metabolism	0.255527892885783	-1.3644237054896	51	3	0.0106382978723404	282	8202	5291,5305,30849	PIK3CB,PIP4K2A,PIK3R4
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.255527892885783	-1.3644237054896	51	3	0.0106382978723404	282	8202	27031,50807,60412	NPHP3,ASAP1,EXOC4
R-HSA-1592230	Mitochondrial biogenesis	0.255527892885783	-1.3644237054896	51	3	0.0106382978723404	282	8202	6907,79718,4208	TBL1X,TBL1XR1,MEF2C
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.25788923757703	-1.35522509795812	254	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,5291,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,PIK3CB,FGF19
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-180336	SHC1 events in EGFR signaling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5673001	RAF/MAP kinase cascade	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-179812	GRB2 events in EGFR signaling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-112412	SOS-mediated signalling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.259029965771408	-1.35081152601599	228	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-917977	Transferrin endocytosis and recycling	0.263082912054348	-1.33528604152728	29	2	0.00709219858156028	282	8202	7037,261729	TFRC,STEAP2
R-HSA-445095	Interaction between L1 and Ankyrins	0.263082912054348	-1.33528604152728	29	2	0.00709219858156028	282	8202	6712,287	SPTBN2,ANK2
R-HSA-180786	Extension of Telomeres	0.263082912054348	-1.33528604152728	29	2	0.00709219858156028	282	8202	5984,8607	RFC4,RUVBL1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.26331491258501	-1.33440457684477	229	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.26331491258501	-1.33440457684477	229	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.26331491258501	-1.33440457684477	229	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.26331491258501	-1.33440457684477	229	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-425986	Sodium/Proton exchangers	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	285195	SLC9A9
R-HSA-70635	Urea cycle	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	384	ARG2
R-HSA-73614	Pyrimidine salvage reactions	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	7378	UPP1
R-HSA-446107	Type I hemidesmosome assembly	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	3914	LAMB3
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	7422	VEGFA
R-HSA-193697	p75NTR regulates axonogenesis	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	84894	LINGO1
R-HSA-2428933	SHC-related events triggered by IGF1R	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	3480	IGF1R
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	3164	NR4A1
R-HSA-3215018	Processing and activation of SUMO	0.270238697690144	-1.30844964502047	9	1	0.00354609929078014	282	8202	205564	SENP5
R-HSA-418555	G alpha (s) signalling events	0.271658511498408	-1.30320947388423	127	6	0.0212765957446809	282	8202	3363,797,5144,5140,2792,50940	HTR7,CALCB,PDE4D,PDE3B,GNGT1,PDE11A
R-HSA-2559585	Oncogene Induced Senescence	0.275976526447226	-1.28743946598612	30	2	0.00709219858156028	282	8202	2113,1021	ETS1,CDK6
R-HSA-72086	mRNA Capping	0.275976526447226	-1.28743946598612	30	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-1236394	Signaling by ERBB4	0.276682078668039	-1.28488616238207	312	13	0.0460992907801418	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,9965,5291	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,FGF19,PIK3CB
R-HSA-5617833	Assembly of the primary cilium	0.278985728730021	-1.27659464997436	180	8	0.0283687943262411	282	8202	80321,50807,55764,60412,5577,80254,27031,7277	CEP70,ASAP1,IFT122,EXOC4,PRKAR2B,CEP63,NPHP3,TUBA4A
R-HSA-2172127	DAP12 interactions	0.280812604146012	-1.27006772127798	340	14	0.049645390070922	282	8202	8660,6712,57761,200734,2534,2247,3164,5922,1852,283455,9542,5577,5291,9965	IRS2,SPTBN2,TRIB3,SPRED2,FYN,FGF2,NR4A1,RASA2,DUSP9,KSR2,NRG2,PRKAR2B,PIK3CB,FGF19
R-HSA-5684996	MAPK1/MAPK3 signaling	0.285073258161887	-1.25500908556213	234	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.288857736227466	-1.24182097425921	31	2	0.00709219858156028	282	8202	2247,9965	FGF2,FGF19
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.288857736227466	-1.24182097425921	31	2	0.00709219858156028	282	8202	7029,25937	TFDP2,WWTR1
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.288857736227466	-1.24182097425921	31	2	0.00709219858156028	282	8202	4316,7077	MMP7,TIMP2
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.289956436477789	-1.23802458632774	424	17	0.0602836879432624	282	8202	6712,200734,2247,5922,2792,1852,283455,9542,23236,9965,8660,6196,2534,11343,5330,1608,3269	SPTBN2,SPRED2,FGF2,RASA2,GNGT1,DUSP9,KSR2,NRG2,PLCB1,FGF19,IRS2,RPS6KA2,FYN,MGLL,PLCB2,DGKG,HRH1
R-HSA-2586552	Signaling by Leptin	0.293919688723917	-1.22444871656625	236	10	0.0354609929078014	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,FGF19
R-HSA-5663084	Diseases of carbohydrate metabolism	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-168799	Neurotoxicity of clostridium toxins	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	6857	SYT1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	30849	PIK3R4
R-HSA-381183	ATF6-alpha activates chaperone genes	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	1649	DDIT3
R-HSA-3229121	Glycogen storage diseases	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-2470946	Cohesin Loading onto Chromatin	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-549127	Organic cation transport	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	55356	SLC22A15
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	64116	SLC39A8
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-419812	Calcitonin-like ligand receptors	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	797	CALCB
R-HSA-1300644	Interaction With The Zona Pellucida	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	7784	ZP3
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-5621480	Dectin-2 family	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	2534	FYN
R-HSA-190377	FGFR2b ligand binding and activation	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.295356809153693	-1.21957113097054	10	1	0.00354609929078014	282	8202	7220	TRPC1
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.303561698092318	-1.19217040053561	81	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.307127774680718	-1.18049141381215	107	5	0.0177304964539007	282	8202	58477,6747,6184,6165,29927	SRPRB,SSR3,RPN1,RPL35A,SEC61A1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.311380386761737	-1.16674000563217	82	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.311380386761737	-1.16674000563217	82	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.311380386761737	-1.16674000563217	82	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-69190	DNA strand elongation	0.314526565779535	-1.15668673652179	33	2	0.00709219858156028	282	8202	5984,4171	RFC4,MCM2
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.314526565779535	-1.15668673652179	33	2	0.00709219858156028	282	8202	5291,5305	PIK3CB,PIP4K2A
R-HSA-5663202	Diseases of signal transduction	0.316318223947305	-1.15100653430971	268	11	0.0390070921985816	282	8202	8660,2534,2247,79718,3164,9542,6907,7048,5291,9965,22943	IRS2,FYN,FGF2,TBL1XR1,NR4A1,NRG2,TBL1X,TGFBR2,PIK3CB,FGF19,DKK1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.31921813826314	-1.14188059088827	83	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.31921813826314	-1.14188059088827	83	4	0.0141843971631206	282	8202	5984,902,8607,86	RFC4,CCNH,RUVBL1,ACTL6A
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	8833	GMPS
R-HSA-2485179	Activation of the phototransduction cascade	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-376172	DSCAM interactions	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-199983	Golgi to ER Retrograde Transport	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	9276	COPB2
R-HSA-199997	COPI Mediated Transport	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	9276	COPB2
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	170506	DHX36
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	10051	SMC4
R-HSA-196807	Nicotinate metabolism	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	349565	NMNAT3
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.319613325247326	-1.14064337244438	11	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-5389840	Mitochondrial translation elongation	0.327071371720222	-1.11757686975925	84	4	0.0141843971631206	282	8202	56945,85476,11222,57129	MRPS22,GFM1,MRPL3,MRPL47
R-HSA-113418	Formation of the Early Elongation Complex	0.327288431714366	-1.11691344269369	34	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-3928663	EPHA-mediated growth cone collapse	0.327288431714366	-1.11691344269369	34	2	0.00709219858156028	282	8202	2534,7422	FYN,VEGFA
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.327288431714366	-1.11691344269369	34	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.327288431714366	-1.11691344269369	34	2	0.00709219858156028	282	8202	9140,84166	ATG12,NLRC5
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.331958403984523	-1.10274560711824	137	6	0.0212765957446809	282	8202	2625,10019,5577,80005,2624,4602	GATA3,SH2B3,PRKAR2B,DOCK5,GATA2,MYB
R-HSA-5683057	MAPK family signaling cascades	0.337936298784203	-1.0848978663964	273	11	0.0390070921985816	282	8202	8660,6712,200734,2534,2247,5922,5062,1852,283455,9542,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,PAK2,DUSP9,KSR2,NRG2,FGF19
R-HSA-73923	Lipid digestion, mobilization, and transport	0.340647565344875	-1.07690686887482	60	3	0.0106382978723404	282	8202	857,3339,11343	CAV1,HSPG2,MGLL
R-HSA-156581	Methylation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	4144	MAT2A
R-HSA-203615	eNOS activation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	857	CAV1
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-190373	FGFR1c ligand binding and activation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	1739	DLG1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	1739	DLG1
R-HSA-390666	Serotonin receptors	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	3363	HTR7
R-HSA-210990	PECAM1 interactions	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2534	FYN
R-HSA-73621	Pyrimidine catabolism	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	7378	UPP1
R-HSA-71384	Ethanol oxidation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	217	ALDH2
R-HSA-176974	Unwinding of DNA	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-190239	FGFR3 ligand binding and activation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-2033514	FGFR3 mutant receptor activation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2644	GCHFR
R-HSA-381033	ATF6-alpha activates chaperones	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	1649	DDIT3
R-HSA-190372	FGFR3c ligand binding and activation	0.34303769862406	-1.06991492933074	12	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-4086398	Ca2+ pathway	0.350138658377623	-1.04942603615881	61	3	0.0106382978723404	282	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-168898	Toll-Like Receptors Cascades	0.350408414929307	-1.04865590499905	140	6	0.0212765957446809	282	8202	5599,6196,9252,170506,4208,30849	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C,PIK3R4
R-HSA-167021	PLC-gamma1 signalling	0.352609464659214	-1.04239416689645	36	2	0.00709219858156028	282	8202	5577,4914	PRKAR2B,NTRK1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.352609464659214	-1.04239416689645	36	2	0.00709219858156028	282	8202	89978,56648	DPH6,EIF5A2
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.352609464659214	-1.04239416689645	36	2	0.00709219858156028	282	8202	7220,2534	TRPC1,FYN
R-HSA-73894	DNA Repair	0.361527619668538	-1.01741683734603	306	12	0.0425531914893617	282	8202	55120,5599,5984,902,11073,8607,545,165918,7486,9656,86,3364	FANCL,MAPK8,RFC4,CCNH,TOPBP1,RUVBL1,ATR,RNF168,WRN,MDC1,ACTL6A,HUS1
R-HSA-69275	G2/M Transition	0.361864716926401	-1.01648484715147	115	5	0.0177304964539007	282	8202	5577,80254,902,80321,7277	PRKAR2B,CEP63,CCNH,CEP70,TUBA4A
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.362758473956123	-1.01401802717057	142	6	0.0212765957446809	282	8202	6196,23236,5330,84254,2792,1739	RPS6KA2,PLCB1,PLCB2,CAMKK1,GNGT1,DLG1
R-HSA-438064	Post NMDA receptor activation events	0.365148109301168	-1.00745222879833	37	2	0.00709219858156028	282	8202	6196,84254	RPS6KA2,CAMKK1
R-HSA-2029481	FCGR activation	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	2534	FYN
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	1803	DPP4
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	170506	DHX36
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	785	CACNB4
R-HSA-209543	p75NTR recruits signalling complexes	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	5584	PRKCI
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	4919	ROR1
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	9542	NRG2
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	30849	PIK3R4
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	140885	SIRPA
R-HSA-1483213	Synthesis of PE	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	23175	LPIN1
R-HSA-190375	FGFR2c ligand binding and activation	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-177504	Retrograde neurotrophin signalling	0.365658378600112	-1.00605577326513	13	1	0.00354609929078014	282	8202	4914	NTRK1
R-HSA-3214847	HATs acetylate histones	0.368943612943284	-0.997111457070122	143	6	0.0212765957446809	282	8202	8464,55167,9575,8607,86,55689	SUPT3H,MSL2,CLOCK,RUVBL1,ACTL6A,YEATS2
R-HSA-196854	Metabolism of vitamins and cofactors	0.374323919569085	-0.982633761307048	90	4	0.0141843971631206	282	8202	5096,349565,5095,56922	PCCB,NMNAT3,PCCA,MCCC1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.374323919569085	-0.982633761307048	90	4	0.0141843971631206	282	8202	5577,80254,80321,7277	PRKAR2B,CEP63,CEP70,TUBA4A
R-HSA-5368287	Mitochondrial translation	0.374323919569085	-0.982633761307048	90	4	0.0141843971631206	282	8202	56945,85476,11222,57129	MRPS22,GFM1,MRPL3,MRPL47
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.374323919569085	-0.982633761307048	90	4	0.0141843971631206	282	8202	5096,349565,5095,56922	PCCB,NMNAT3,PCCA,MCCC1
R-HSA-453274	Mitotic G2-G2/M phases	0.375631802824441	-0.979145863175953	117	5	0.0177304964539007	282	8202	5577,80254,902,80321,7277	PRKAR2B,CEP63,CCNH,CEP70,TUBA4A
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.377593121476811	-0.973938061304649	38	2	0.00709219858156028	282	8202	5599,5366	MAPK8,PMAIP1
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.377593121476811	-0.973938061304649	38	2	0.00709219858156028	282	8202	8607,86	RUVBL1,ACTL6A
R-HSA-449147	Signaling by Interleukins	0.382631244803158	-0.960683560900624	311	12	0.0425531914893617	282	8202	8660,6712,200734,2534,2247,5922,1852,283455,9542,3606,5291,9965	IRS2,SPTBN2,SPRED2,FYN,FGF2,RASA2,DUSP9,KSR2,NRG2,IL18,PIK3CB,FGF19
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	5742	PTGS1
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-428540	Activation of Rac	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-418885	DCC mediated attractive signaling	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	2534	FYN
R-HSA-69091	Polymerase switching	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-69109	Leading Strand Synthesis	0.387502845226375	-0.948032087696014	14	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-6783310	Fanconi Anemia Pathway	0.389936124007191	-0.941772337869554	39	2	0.00709219858156028	282	8202	55120,545	FANCL,ATR
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.390047530968701	-0.941486673005791	92	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.390047530968701	-0.941486673005791	92	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.390047530968701	-0.941486673005791	92	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.390047530968701	-0.941486673005791	92	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-556833	Metabolism of lipids and lipoproteins	0.40687758859268	-0.899242903906995	628	23	0.0815602836879433	282	8202	5096,3339,79718,5095,56895,259230,30849,857,5291,5305,23175,57761,1490,622,406,25937,5742,1800,8309,5337,6907,9575,11343	PCCB,HSPG2,TBL1XR1,PCCA,AGPAT4,SGMS1,PIK3R4,CAV1,PIK3CB,PIP4K2A,LPIN1,TRIB3,CTGF,BDH1,ARNTL,WWTR1,PTGS1,DPEP1,ACOX2,PLD1,TBL1X,CLOCK,MGLL
R-HSA-1643685	Disease	0.408567754988761	-0.895097515550223	657	24	0.0851063829787234	282	8202	118429,5096,902,3339,2247,79718,3164,5095,56922,9542,2992,6857,84168,7048,9965,5291,22943,8660,6165,3840,2534,5062,22916,6907	ANTXR2,PCCB,CCNH,HSPG2,FGF2,TBL1XR1,NR4A1,PCCA,MCCC1,NRG2,GYG1,SYT1,ANTXR1,TGFBR2,FGF19,PIK3CB,DKK1,IRS2,RPL35A,KPNA4,FYN,PAK2,NCBP2,TBL1X
R-HSA-3322077	Glycogen synthesis	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	54464	XRN1
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	23175	LPIN1
R-HSA-549132	Organic cation/anion/zwitterion transport	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	55356	SLC22A15
R-HSA-205043	NRIF signals cell death from the nucleus	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.408597642199507	-0.895024367052104	15	1	0.00354609929078014	282	8202	22943	DKK1
R-HSA-2682334	EPH-Ephrin signaling	0.413524308383226	-0.883038979346089	95	4	0.0141843971631206	282	8202	2534,2047,7422,5062	FYN,EPHB1,VEGFA,PAK2
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.414285966624197	-0.881198802970181	41	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.414285966624197	-0.881198802970181	41	2	0.00709219858156028	282	8202	6196,84254	RPS6KA2,CAMKK1
R-HSA-388841	Costimulation by the CD28 family	0.415891763962194	-0.877330235357475	68	3	0.0106382978723404	282	8202	57761,2534,5062	TRIB3,FYN,PAK2
R-HSA-1483206	Glycerophospholipid biosynthesis	0.421309778089202	-0.864386900940122	96	4	0.0141843971631206	282	8202	5337,11343,56895,23175	PLD1,MGLL,AGPAT4,LPIN1
R-HSA-3928662	EPHB-mediated forward signaling	0.426279319118847	-0.852660468893379	42	2	0.00709219858156028	282	8202	2534,2047	FYN,EPHB1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.426279319118847	-0.852660468893379	42	2	0.00709219858156028	282	8202	5577,2792	PRKAR2B,GNGT1
R-HSA-375280	Amine ligand-binding receptors	0.426279319118847	-0.852660468893379	42	2	0.00709219858156028	282	8202	3363,3269	HTR7,HRH1
R-HSA-110312	Translesion synthesis by REV1	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-193639	p75NTR signals via NF-kB	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	5584	PRKCI
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	5599	MAPK8
R-HSA-163615	PKA activation	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-190242	FGFR1 ligand binding and activation	0.428968408643856	-0.846372002290454	16	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.429070771603747	-0.846133404886669	97	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.429070771603747	-0.846133404886669	97	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.429070771603747	-0.846133404886669	97	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-69473	G2/M DNA damage checkpoint	0.434321739609627	-0.833969684029115	70	3	0.0106382978723404	282	8202	165918,545,9656	RNF168,ATR,MDC1
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.438143618320085	-0.825208526643783	43	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.438143618320085	-0.825208526643783	43	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-917937	Iron uptake and transport	0.438143618320085	-0.825208526643783	43	2	0.00709219858156028	282	8202	7037,261729	TFRC,STEAP2
R-HSA-167169	HIV Transcription Elongation	0.438143618320085	-0.825208526643783	43	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.438143618320085	-0.825208526643783	43	2	0.00709219858156028	282	8202	5577,2792	PRKAR2B,GNGT1
R-HSA-1296071	Potassium Channels	0.444509294382082	-0.810784314500816	99	4	0.0141843971631206	282	8202	3749,2792,3755,8514	KCNC4,GNGT1,KCNG1,KCNAB2
R-HSA-2033519	Activated point mutants of FGFR2	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-1839126	FGFR2 mutant receptor activation	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-5656121	Translesion synthesis by POLI	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-5655862	Translesion synthesis by POLK	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	54464	XRN1
R-HSA-435354	Zinc transporters	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	64116	SLC39A8
R-HSA-2142845	Hyaluronan metabolism	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	10057	ABCC5
R-HSA-164378	PKA activation in glucagon signalling	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-174800	Chylomicron-mediated lipid transport	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	2992	GYG1
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.448639909843503	-0.80153469553109	17	1	0.00354609929078014	282	8202	54464	XRN1
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.449873548380313	-0.798788739305985	44	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.449873548380313	-0.798788739305985	44	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-112382	Formation of RNA Pol II elongation complex	0.449873548380313	-0.798788739305985	44	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.459820605260646	-0.776918854128125	101	4	0.0141843971631206	282	8202	55356,6536,64116,9194	SLC22A15,SLC6A9,SLC39A8,SLC16A7
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.467636066882685	-0.760064920445382	18	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.467636066882685	-0.760064920445382	18	1	0.00354609929078014	282	8202	30849	PIK3R4
R-HSA-156584	Cytosolic sulfonation of small molecules	0.467636066882685	-0.760064920445382	18	1	0.00354609929078014	282	8202	6820	SULT2B1
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.470503770035406	-0.753951307161162	74	3	0.0106382978723404	282	8202	5599,165918,9656	MAPK8,RNF168,MDC1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.472911584167418	-0.748846833613259	46	2	0.00709219858156028	282	8202	5577,2247	PRKAR2B,FGF2
R-HSA-5693606	DNA Double Strand Break Response	0.479389008069108	-0.735242885761387	75	3	0.0106382978723404	282	8202	5599,165918,9656	MAPK8,RNF168,MDC1
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.484211519235503	-0.725233444518489	47	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-110320	Translesion Synthesis by POLH	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.485979985393802	-0.721587838246937	19	1	0.00354609929078014	282	8202	6536	SLC6A9
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.495360690101751	-0.702469114890034	48	2	0.00709219858156028	282	8202	2534,2047	FYN,EPHB1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.495360690101751	-0.702469114890034	48	2	0.00709219858156028	282	8202	5291,2792	PIK3CB,GNGT1
R-HSA-70326	Glucose metabolism	0.496946976588564	-0.699271945521504	77	3	0.0106382978723404	282	8202	2992,5106,3099	GYG1,PCK2,HK2
R-HSA-1483191	Synthesis of PC	0.503693983207936	-0.685786371491601	20	1	0.00354609929078014	282	8202	23175	LPIN1
R-HSA-190241	FGFR2 ligand binding and activation	0.503693983207936	-0.685786371491601	20	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.503693983207936	-0.685786371491601	20	1	0.00354609929078014	282	8202	1803	DPP4
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.50635608050244	-0.680515140778976	49	2	0.00709219858156028	282	8202	5577,2247	PRKAR2B,FGF2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.517195057788224	-0.659335187837315	50	2	0.00709219858156028	282	8202	54464,1974	XRN1,EIF4A2
R-HSA-168249	Innate Immune System	0.519100694581376	-0.655657398100578	752	26	0.0921985815602837	282	8202	5599,6712,200734,1604,2247,3164,5922,30849,1852,9140,9542,283455,5577,9252,5291,9965,7462,8660,57761,2534,6196,5062,84166,5337,170506,4208	MAPK8,SPTBN2,SPRED2,CD55,FGF2,NR4A1,RASA2,PIK3R4,DUSP9,ATG12,NRG2,KSR2,PRKAR2B,RPS6KA5,PIK3CB,FGF19,LAT2,IRS2,TRIB3,FYN,RPS6KA2,PAK2,NLRC5,PLD1,DHX36,MEF2C
R-HSA-5696398	Nucleotide Excision Repair	0.5194526815398	-0.654979557211522	109	4	0.0141843971631206	282	8202	5984,902,8607,86	RFC4,CCNH,RUVBL1,ACTL6A
R-HSA-2024096	HS-GAG degradation	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	59352	LGR6
R-HSA-390918	Peroxisomal lipid metabolism	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	8309	ACOX2
R-HSA-69186	Lagging Strand Synthesis	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-445144	Signal transduction by L1	0.520799617145253	-0.652389923216211	21	1	0.00354609929078014	282	8202	8829	NRP1
R-HSA-162582	Signal Transduction	0.525201690813687	-0.643972917187606	2357	81	0.287234042553192	282	8202	5599,6712,200734,2736,3339,9500,58504,9542,84894,6196,5144,11343,5796,1604,4914,1894,283455,5577,857,4919,7422,29,3363,8660,6498,2534,8607,55764,25937,2887,797,7029,8829,90627,59352,4208,64411,5922,2792,30849,4983,1287,5585,5217,7048,9252,9965,1293,84144,1123,10019,58191,6696,3480,23263,5062,5584,57522,5330,1608,114793,51421,2247,79718,3164,1852,84033,9743,5140,23236,5291,9901,22943,50940,57761,55733,6259,101928168,2863,6907,3269	MAPK8,SPTBN2,SPRED2,GLI2,HSPG2,MAGED1,ARHGAP22,NRG2,LINGO1,RPS6KA2,PDE4D,MGLL,PTPRK,CD55,NTRK1,ECT2,KSR2,PRKAR2B,CAV1,ROR1,VEGFA,ABR,HTR7,IRS2,SKIL,FYN,RUVBL1,IFT122,WWTR1,GRB10,CALCB,TFDP2,NRP1,STARD13,LGR6,MEF2C,ARAP3,RASA2,GNGT1,PIK3R4,OPHN1,COL4A5,PKN1,PFN2,TGFBR2,RPS6KA5,FGF19,COL6A3,SYDE2,CHN1,SH2B3,CXCL16,SPP1,IGF1R,MCF2L,PAK2,PRKCI,SRGAP1,PLCB2,DGKG,FMNL2,AMOTL2,FGF2,TBL1XR1,NR4A1,DUSP9,OBSCN,ARHGAP32,PDE3B,PLCB1,PIK3CB,SRGAP3,DKK1,PDE11A,TRIB3,HHAT,RYK,LOC101928168,GPR39,TBL1X,HRH1
R-HSA-383280	Nuclear Receptor transcription pathway	0.527875350223476	-0.638895102269143	51	2	0.00709219858156028	282	8202	3164,7182	NR4A1,NR2C2
R-HSA-445717	Aquaporin-mediated transport	0.527875350223476	-0.638895102269143	51	2	0.00709219858156028	282	8202	5577,2792	PRKAR2B,GNGT1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.527875350223476	-0.638895102269143	51	2	0.00709219858156028	282	8202	5577,2247	PRKAR2B,FGF2
R-HSA-114608	Platelet degranulation	0.531144388690199	-0.63272137626603	81	3	0.0106382978723404	282	8202	7273,7422,7277	TTN,VEGFA,TUBA4A
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.531144388690199	-0.63272137626603	81	3	0.0106382978723404	282	8202	9140,170506,84166	ATG12,DHX36,NLRC5
R-HSA-5423646	Aflatoxin activation and detoxification	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	1800	DPEP1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	9140	ATG12
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-5655332	Signaling by FGFR3 in disease	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-5205647	Mitophagy	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	9140	ATG12
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-389513	CTLA4 inhibitory signaling	0.537317708805054	-0.621165722912671	22	1	0.00354609929078014	282	8202	2534	FYN
R-HSA-76002	Platelet activation, signaling and aggregation	0.538133671053157	-0.619648290474618	230	8	0.0283687943262411	282	8202	7273,2534,2792,7422,1608,11343,5291,7277	TTN,FYN,GNGT1,VEGFA,DGKG,MGLL,PIK3CB,TUBA4A
R-HSA-15869	Metabolism of nucleotides	0.539489857119753	-0.617131294980137	82	3	0.0106382978723404	282	8202	8833,131870,7378	GMPS,NUDT16,UPP1
R-HSA-166054	Activated TLR4 signalling	0.541017641111151	-0.614303392328754	112	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-73980	RNA Polymerase III Transcription Termination	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	4774	NFIA
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	1803	DPP4
R-HSA-429947	Deadenylation of mRNA	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	1974	EIF4A2
R-HSA-5627123	RHO GTPases activate PAKs	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	6498	SKIL
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-428930	Thromboxane signalling through TP receptor	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-112409	RAF-independent MAPK1/3 activation	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	1852	DUSP9
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	1800	DPEP1
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.553268369697761	-0.591912097352738	23	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-3858494	Beta-catenin independent WNT signaling	0.555282178097901	-0.588278865436709	144	5	0.0177304964539007	282	8202	4919,23236,5330,2792,6259	ROR1,PLCB1,PLCB2,GNGT1,RYK
R-HSA-5419276	Mitochondrial translation termination	0.555923330827847	-0.587124888434354	84	3	0.0106382978723404	282	8202	56945,11222,57129	MRPS22,MRPL3,MRPL47
R-HSA-5368286	Mitochondrial translation initiation	0.555923330827847	-0.587124888434354	84	3	0.0106382978723404	282	8202	56945,11222,57129	MRPS22,MRPL3,MRPL47
R-HSA-114604	GPVI-mediated activation cascade	0.558946370582896	-0.581701748563749	54	2	0.00709219858156028	282	8202	2534,5291	FYN,PIK3CB
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.558946370582896	-0.581701748563749	54	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.558946370582896	-0.581701748563749	54	2	0.00709219858156028	282	8202	152503,7037	SH3D19,TFRC
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.562083051421672	-0.57610566167621	115	4	0.0141843971631206	282	8202	10225,3903,10666,945	CD96,LAIR1,CD226,CD33
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.568671025245242	-0.564453175070126	24	1	0.00354609929078014	282	8202	3164	NR4A1
R-HSA-379716	Cytosolic tRNA aminoacylation	0.568671025245242	-0.564453175070126	24	1	0.00354609929078014	282	8202	833	CARS
R-HSA-977606	Regulation of Complement cascade	0.568671025245242	-0.564453175070126	24	1	0.00354609929078014	282	8202	1604	CD55
R-HSA-73848	Pyrimidine metabolism	0.568671025245242	-0.564453175070126	24	1	0.00354609929078014	282	8202	7378	UPP1
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.568671025245242	-0.564453175070126	24	1	0.00354609929078014	282	8202	8309	ACOX2
R-HSA-2142753	Arachidonic acid metabolism	0.568975693198456	-0.563917564224406	55	2	0.00709219858156028	282	8202	1800,5742	DPEP1,PTGS1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.572003317777993	-0.558610487307985	86	3	0.0106382978723404	282	8202	2534,5337,5291	FYN,PLD1,PIK3CB
R-HSA-2980736	Peptide hormone metabolism	0.572003317777993	-0.558610487307985	86	3	0.0106382978723404	282	8202	3800,1803,60412	KIF5C,DPP4,EXOC4
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.572003317777993	-0.558610487307985	86	3	0.0106382978723404	282	8202	7273,7422,7277	TTN,VEGFA,TUBA4A
R-HSA-3000178	ECM proteoglycans	0.578839668247521	-0.546729751245808	56	2	0.00709219858156028	282	8202	3687,3673	ITGAX,ITGA2
R-HSA-373080	Class B/2 (Secretin family receptors)	0.579907395002347	-0.544886851978349	87	3	0.0106382978723404	282	8202	797,1604,2792	CALCB,CD55,GNGT1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-977068	Termination of O-glycan biosynthesis	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	6480	ST6GAL1
R-HSA-1296059	G protein gated Potassium channels	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-1538133	G0 and Early G1	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	7029	TFDP2
R-HSA-425410	Metal ion SLC transporters	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	64116	SLC39A8
R-HSA-3295583	TRP channels	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	7220	TRPC1
R-HSA-982772	Growth hormone receptor signaling	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	8660	IRS2
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-2262749	Cellular response to hypoxia	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	7422	VEGFA
R-HSA-1296041	Activation of G protein gated Potassium channels	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.583544438181761	-0.538634672174659	25	1	0.00354609929078014	282	8202	7422	VEGFA
R-HSA-69620	Cell Cycle Checkpoints	0.583913771664273	-0.538001958315237	179	6	0.0212765957446809	282	8202	5984,165918,545,9656,4171,3364	RFC4,RNF168,ATR,MDC1,MCM2,HUS1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.588537772279217	-0.530114170349638	57	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.588537772279217	-0.530114170349638	57	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.588537772279217	-0.530114170349638	57	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.588537772279217	-0.530114170349638	57	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.588537772279217	-0.530114170349638	57	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.595438034095947	-0.518457952534838	89	3	0.0106382978723404	282	8202	5742,217,4129	PTGS1,ALDH2,MAOB
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	7486	WRN
R-HSA-3781865	Diseases of glycosylation	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-1474165	Reproduction	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	7784	ZP3
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-1187000	Fertilization	0.597906731002738	-0.51432050541866	26	1	0.00354609929078014	282	8202	7784	ZP3
R-HSA-71291	Metabolism of amino acids and derivatives	0.597994615607413	-0.514173529073023	212	7	0.024822695035461	282	8202	384,84706,440,29968,26227,594,56922	ARG2,GPT2,ASNS,PSAT1,PHGDH,BCKDHB,MCCC1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.602586546072069	-0.506523979000379	121	4	0.0141843971631206	282	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.611775407840076	-0.49139004447716	27	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-182971	EGFR downregulation	0.611775407840076	-0.49139004447716	27	1	0.00354609929078014	282	8202	5796	PTPRK
R-HSA-192105	Synthesis of bile acids and bile salts	0.611775407840076	-0.49139004447716	27	1	0.00354609929078014	282	8202	8309	ACOX2
R-HSA-5655253	Signaling by FGFR2 in disease	0.611775407840076	-0.49139004447716	27	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-400685	Sema4D in semaphorin signaling	0.611775407840076	-0.49139004447716	27	1	0.00354609929078014	282	8202	4233	MET
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-111933	Calmodulin induced events	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-111997	CaM pathway	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-202040	G-protein activation	0.625167375427458	-0.469735864414006	28	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-69242	S Phase	0.628302549967644	-0.464733461062222	125	4	0.0141843971631206	282	8202	5984,902,10274,4171	RFC4,CCNH,STAG1,MCM2
R-HSA-375170	CDO in myogenesis	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	4208	MEF2C
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	7029	TFDP2
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-525793	Myogenesis	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	4208	MEF2C
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	6196	RPS6KA2
R-HSA-1839124	FGFR1 mutant receptor activation	0.638098963414166	-0.44926189259722	29	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-416476	G alpha (q) signalling events	0.64212489917347	-0.442972447214815	190	6	0.0212765957446809	282	8202	1608,23236,5330,11343,2792,3269	DGKG,PLCB1,PLCB2,MGLL,GNGT1,HRH1
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.643240997418255	-0.441235823381486	63	2	0.00709219858156028	282	8202	5984,902	RFC4,CCNH
R-HSA-109581	Apoptosis	0.649036476151441	-0.432266360234236	160	5	0.0177304964539007	282	8202	5599,90249,5366,9500,5062	MAPK8,UNC5A,PMAIP1,MAGED1,PAK2
R-HSA-399719	Trafficking of AMPA receptors	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	1739	DLG1
R-HSA-111996	Ca-dependent events	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-5656169	Termination of translesion DNA synthesis	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-174824	Lipoprotein metabolism	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-420092	Glucagon-type ligand receptors	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-68962	Activation of the pre-replicative complex	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	1739	DLG1
R-HSA-420029	Tight junction interactions	0.650585943995715	-0.429881869855467	30	1	0.00354609929078014	282	8202	5584	PRKCI
R-HSA-6782135	Dual incision in TC-NER	0.651780900555947	-0.428046815622386	64	2	0.00709219858156028	282	8202	5984,902	RFC4,CCNH
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.660157865695342	-0.415276282115652	65	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-211859	Biological oxidations	0.662050179984049	-0.412413925337713	194	6	0.0212765957446809	282	8202	1800,5742,217,4129,6820,4144	DPEP1,PTGS1,ALDH2,MAOB,SULT2B1,MAT2A
R-HSA-1296065	Inwardly rectifying K+ channels	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-70263	Gluconeogenesis	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	5106	PCK2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	857	CAV1
R-HSA-73772	RNA Polymerase I Promoter Escape	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-70171	Glycolysis	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	3099	HK2
R-HSA-2022928	HS-GAG biosynthesis	0.662643550912651	-0.411518063970746	31	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-5357801	Programmed Cell Death	0.665166406814588	-0.407718033818631	163	5	0.0177304964539007	282	8202	5599,90249,5366,9500,5062	MAPK8,UNC5A,PMAIP1,MAGED1,PAK2
R-HSA-5610787	Hedgehog 'off' state	0.667347935899344	-0.404443726047438	99	3	0.0106382978723404	282	8202	5577,2736,55764	PRKAR2B,GLI2,IFT122
R-HSA-392518	Signal amplification	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-202433	Generation of second messenger molecules	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	7048	TGFBR2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-73863	RNA Polymerase I Transcription Termination	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.674286497754035	-0.394100187535167	32	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-5658442	Regulation of RAS by GAPs	0.676427367831322	-0.39093020176009	67	2	0.00709219858156028	282	8202	200734,5922	SPRED2,RASA2
R-HSA-167172	Transcription of the HIV genome	0.676427367831322	-0.39093020176009	67	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-1632852	Macroautophagy	0.676427367831322	-0.39093020176009	67	2	0.00709219858156028	282	8202	9140,30849	ATG12,PIK3R4
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.676427367831322	-0.39093020176009	67	2	0.00709219858156028	282	8202	10195,6480	ALG3,ST6GAL1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.68432238612285	-0.379326147657195	68	2	0.00709219858156028	282	8202	165918,9656	RNF168,MDC1
R-HSA-75109	Triglyceride Biosynthesis	0.68432238612285	-0.379326147657195	68	2	0.00709219858156028	282	8202	56895,23175	AGPAT4,LPIN1
R-HSA-909733	Interferon alpha/beta signaling	0.68432238612285	-0.379326147657195	68	2	0.00709219858156028	282	8202	1958,3669	EGR1,ISG20
R-HSA-73847	Purine metabolism	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	8833	GMPS
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-933541	TRAF6 mediated IRF7 activation	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	170506	DHX36
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	7486	WRN
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-4085001	Sialic acid metabolism	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	6480	ST6GAL1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-72187	mRNA 3'-end processing	0.685528995627535	-0.377564482365885	33	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-453279	Mitotic G1-G1/S phases	0.687809489688124	-0.374243383917005	135	4	0.0141843971631206	282	8202	902,7029,4171,1021	CCNH,TFDP2,MCM2,CDK6
R-HSA-5358351	Signaling by Hedgehog	0.687809489688124	-0.374243383917005	135	4	0.0141843971631206	282	8202	5577,2736,55764,55733	PRKAR2B,GLI2,IFT122,HHAT
R-HSA-390522	Striated Muscle Contraction	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	7273	TTN
R-HSA-4791275	Signaling by WNT in cancer	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	22943	DKK1
R-HSA-1489509	DAG and IP3 signaling	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-1222556	ROS production in response to bacteria	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	4842	NOS1
R-HSA-5693537	Resolution of D-Loop Structures	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	7486	WRN
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.696384770300435	-0.361852940510989	34	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.699639930505495	-0.357189461272227	70	2	0.00709219858156028	282	8202	3840,1974	KPNA4,EIF4A2
R-HSA-1169408	ISG15 antiviral mechanism	0.699639930505495	-0.357189461272227	70	2	0.00709219858156028	282	8202	3840,1974	KPNA4,EIF4A2
R-HSA-421837	Clathrin derived vesicle budding	0.699639930505495	-0.357189461272227	70	2	0.00709219858156028	282	8202	152503,7037	SH3D19,TFRC
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.699639930505495	-0.357189461272227	70	2	0.00709219858156028	282	8202	152503,7037	SH3D19,TFRC
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.706867078670677	-0.346912638299137	35	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-2514856	The phototransduction cascade	0.706867078670677	-0.346912638299137	35	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-73884	Base Excision Repair	0.706867078670677	-0.346912638299137	35	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-194068	Bile acid and bile salt metabolism	0.706867078670677	-0.346912638299137	35	1	0.00354609929078014	282	8202	8309	ACOX2
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.706867078670677	-0.346912638299137	35	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-1980143	Signaling by NOTCH1	0.714337825123305	-0.336399284109685	72	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.716988724769813	-0.332695164071279	36	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-5655302	Signaling by FGFR1 in disease	0.716988724769813	-0.332695164071279	36	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.716988724769813	-0.332695164071279	36	1	0.00354609929078014	282	8202	259230	SGMS1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.716988724769813	-0.332695164071279	36	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.72145857018594	-0.326480324196614	73	2	0.00709219858156028	282	8202	83667,54541	SESN2,DDIT4
R-HSA-3700989	Transcriptional Regulation by TP53	0.72145857018594	-0.326480324196614	73	2	0.00709219858156028	282	8202	83667,54541	SESN2,DDIT4
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.726762075209371	-0.319156124326013	37	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.726762075209371	-0.319156124326013	37	1	0.00354609929078014	282	8202	5577	PRKAR2B
R-HSA-157118	Signaling by NOTCH	0.73519526372567	-0.307619150119096	110	3	0.0106382978723404	282	8202	6907,7029,79718	TBL1X,TFDP2,TBL1XR1
R-HSA-1221632	Meiotic synapsis	0.73525256504737	-0.307541212880374	75	2	0.00709219858156028	282	8202	545,10274	ATR,STAG1
R-HSA-5674135	MAP2K and MAPK activation	0.736199073959964	-0.306254715902767	38	1	0.00354609929078014	282	8202	283455	KSR2
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.736199073959964	-0.306254715902767	38	1	0.00354609929078014	282	8202	9197	SLC33A1
R-HSA-166658	Complement cascade	0.736199073959964	-0.306254715902767	38	1	0.00354609929078014	282	8202	1604	CD55
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.736199073959964	-0.306254715902767	38	1	0.00354609929078014	282	8202	3840	KPNA4
R-HSA-977444	GABA B receptor activation	0.745311256856971	-0.293953353415486	39	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-991365	Activation of GABAB receptors	0.745311256856971	-0.293953353415486	39	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.745311256856971	-0.293953353415486	39	1	0.00354609929078014	282	8202	23145	SSPO
R-HSA-72737	Cap-dependent Translation Initiation	0.746285517420203	-0.292647020874974	112	3	0.0106382978723404	282	8202	6165,8893,1974	RPL35A,EIF2B5,EIF4A2
R-HSA-72613	Eukaryotic Translation Initiation	0.746285517420203	-0.292647020874974	112	3	0.0106382978723404	282	8202	6165,8893,1974	RPL35A,EIF2B5,EIF4A2
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.748462413954598	-0.289734291540794	77	2	0.00709219858156028	282	8202	5984,902	RFC4,CCNH
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	4774	NFIA
R-HSA-1251985	Nuclear signaling by ERBB4	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	9542	NRG2
R-HSA-5675221	Negative regulation of MAPK pathway	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	1852	DUSP9
R-HSA-168253	Host Interactions with Influenza Factors	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	3840	KPNA4
R-HSA-5696400	Dual Incision in GG-NER	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-74158	RNA Polymerase III Transcription	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	4774	NFIA
R-HSA-109703	PKB-mediated events	0.754109765429592	-0.282217344076728	40	1	0.00354609929078014	282	8202	5140	PDE3B
R-HSA-157579	Telomere Maintenance	0.754853146289989	-0.281232056877471	78	2	0.00709219858156028	282	8202	5984,8607	RFC4,RUVBL1
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.754853146289989	-0.281232056877471	78	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-5620924	Intraflagellar transport	0.762605360398218	-0.271014602474778	41	1	0.00354609929078014	282	8202	55764	IFT122
R-HSA-70153	Glucose transport	0.762605360398218	-0.271014602474778	41	1	0.00354609929078014	282	8202	3099	HK2
R-HSA-1280215	Cytokine Signaling in Immune system	0.766254842456022	-0.26624047207009	539	16	0.0567375886524823	282	8202	6712,200734,1958,2247,5922,1974,1852,283455,9542,3606,5291,9965,3669,8660,3840,2534	SPTBN2,SPRED2,EGR1,FGF2,RASA2,EIF4A2,DUSP9,KSR2,NRG2,IL18,PIK3CB,FGF19,ISG20,IRS2,KPNA4,FYN
R-HSA-1640170	Cell Cycle	0.770226107152731	-0.261071161586957	572	17	0.0602836879432624	282	8202	5984,902,80321,10274,5577,9656,4171,3364,23175,8607,165918,545,80254,7029,1021,10051,7277	RFC4,CCNH,CEP70,STAG1,PRKAR2B,MDC1,MCM2,HUS1,LPIN1,RUVBL1,RNF168,ATR,CEP63,TFDP2,CDK6,SMC4,TUBA4A
R-HSA-73856	RNA Polymerase II Transcription Termination	0.770808434583408	-0.260315399866342	42	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-379724	tRNA Aminoacylation	0.770808434583408	-0.260315399866342	42	1	0.00354609929078014	282	8202	833	CARS
R-HSA-975634	Retinoid metabolism and transport	0.770808434583408	-0.260315399866342	42	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-1566948	Elastic fibre formation	0.770808434583408	-0.260315399866342	42	1	0.00354609929078014	282	8202	84467	FBN3
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.770808434583408	-0.260315399866342	42	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-611105	Respiratory electron transport	0.773192778336662	-0.257226871659683	81	2	0.00709219858156028	282	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-1280218	Adaptive Immune System	0.775292188753091	-0.254515302936199	668	20	0.0709219858156028	282	8202	6712,92369,2247,3164,7879,7328,9542,10666,5291,9965,8660,10225,57761,2534,29927,79876,5062,7220,3903,945	SPTBN2,SPSB4,FGF2,NR4A1,RAB7A,UBE2H,NRG2,CD226,PIK3CB,FGF19,IRS2,CD96,TRIB3,FYN,SEC61A1,UBA5,PAK2,TRPC1,LAIR1,CD33
R-HSA-2559583	Cellular Senescence	0.776393097526989	-0.25309631808359	187	5	0.0177304964539007	282	8202	5599,6196,80012,2113,1021	MAPK8,RPS6KA2,PHC3,ETS1,CDK6
R-HSA-2559580	Oxidative Stress Induced Senescence	0.782207812006012	-0.245634829487364	119	3	0.0106382978723404	282	8202	5599,80012,1021	MAPK8,PHC3,CDK6
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.786376827238891	-0.240319177471828	44	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-382556	ABC-family proteins mediated transport	0.786376827238891	-0.240319177471828	44	1	0.00354609929078014	282	8202	10057	ABCC5
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.793761202673343	-0.23097261527062	45	1	0.00354609929078014	282	8202	7029	TFDP2
R-HSA-1226099	Signaling by FGFR in disease	0.793761202673343	-0.23097261527062	45	1	0.00354609929078014	282	8202	2247	FGF2
R-HSA-195721	Signaling by Wnt	0.796112886124739	-0.228014286453176	326	9	0.0319148936170213	282	8202	8607,2792,6259,857,4919,5330,23236,22943,59352	RUVBL1,GNGT1,RYK,CAV1,ROR1,PLCB2,PLCB1,DKK1,LGR6
R-HSA-5621481	C-type lectin receptors (CLRs)	0.800790211332509	-0.222156274666588	123	3	0.0106382978723404	282	8202	2534,9252,5062	FYN,RPS6KA5,PAK2
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-73776	RNA Polymerase II Promoter Escape	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-167161	HIV Transcription Initiation	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-73893	DNA Damage Bypass	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	5984	RFC4
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-418597	G alpha (z) signalling events	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.800891194197205	-0.222030178597194	46	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-446728	Cell junction organization	0.801108641765243	-0.221758708445334	86	2	0.00709219858156028	282	8202	5584,3914	PRKCI,LAMB3
R-HSA-189200	Hexose transport	0.807775534959908	-0.213471062322958	47	1	0.00354609929078014	282	8202	3099	HK2
R-HSA-977225	Amyloid formation	0.811396959986846	-0.208997874843816	88	2	0.00709219858156028	282	8202	3339,23621	HSPG2,BACE1
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.81442265931339	-0.205275810250997	48	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.816361532998945	-0.202897966992215	89	2	0.00709219858156028	282	8202	6165,22916	RPL35A,NCBP2
R-HSA-168256	Immune System	0.819411109502833	-0.199169355866533	1371	42	0.148936170212766	282	8202	5599,6712,200734,1958,5922,30849,9542,3606,4842,9252,10666,9965,10225,6196,5062,79876,7220,1604,92369,2247,3164,7879,1974,7328,1852,283455,9140,5577,5291,7462,3669,8660,57761,2534,3840,29927,84166,5337,3903,170506,945,4208	MAPK8,SPTBN2,SPRED2,EGR1,RASA2,PIK3R4,NRG2,IL18,NOS1,RPS6KA5,CD226,FGF19,CD96,RPS6KA2,PAK2,UBA5,TRPC1,CD55,SPSB4,FGF2,NR4A1,RAB7A,EIF4A2,UBE2H,DUSP9,KSR2,ATG12,PRKAR2B,PIK3CB,LAT2,ISG20,IRS2,TRIB3,FYN,KPNA4,SEC61A1,NLRC5,PLD1,LAIR1,DHX36,CD33,MEF2C
R-HSA-390466	Chaperonin-mediated protein folding	0.820840713035846	-0.197426204143895	49	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.820840713035846	-0.197426204143895	49	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-4086400	PCP/CE pathway	0.825942197871013	-0.19123048627415	91	2	0.00709219858156028	282	8202	4919,6259	ROR1,RYK
R-HSA-169911	Regulation of Apoptosis	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-191859	snRNP Assembly	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-194441	Metabolism of non-coding RNA	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-2980766	Nuclear Envelope Breakdown	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	23175	LPIN1
R-HSA-72165	mRNA Splicing - Minor Pathway	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.827037563155826	-0.189905164003459	50	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.833020807400581	-0.182696658255015	51	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-75153	Apoptotic execution  phase	0.838797783505424	-0.175785622416824	52	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.838797783505424	-0.175785622416824	52	1	0.00354609929078014	282	8202	6480	ST6GAL1
R-HSA-3214815	HDACs deacetylate histones	0.839473853445863	-0.174979948338655	94	2	0.00709219858156028	282	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-1430728	Metabolism	0.840060256385574	-0.174281655925173	1691	52	0.184397163120567	282	8202	384,84706,349565,3339,91942,259230,2792,4711,56922,30849,2992,26227,5305,23175,440,1490,2644,622,8833,5742,8309,776,5106,6812,4129,5330,11343,6820,10057,5096,217,29968,79718,594,56895,7378,5095,5577,857,23236,5291,4144,131870,23007,57761,406,25937,3099,1800,6907,5337,9575	ARG2,GPT2,NMNAT3,HSPG2,NDUFAF2,SGMS1,GNGT1,NDUFB5,MCCC1,PIK3R4,GYG1,PHGDH,PIP4K2A,LPIN1,ASNS,CTGF,GCHFR,BDH1,GMPS,PTGS1,ACOX2,CACNA1D,PCK2,STXBP1,MAOB,PLCB2,MGLL,SULT2B1,ABCC5,PCCB,ALDH2,PSAT1,TBL1XR1,BCKDHB,AGPAT4,UPP1,PCCA,PRKAR2B,CAV1,PLCB1,PIK3CB,MAT2A,NUDT16,PLCH1,TRIB3,ARNTL,WWTR1,HK2,DPEP1,TBL1X,PLD1,CLOCK
R-HSA-948021	Transport to the Golgi and subsequent modification	0.843769002798386	-0.169876515213886	95	2	0.00709219858156028	282	8202	6480,4249	ST6GAL1,MGAT5
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.849761034744702	-0.162800104618263	54	1	0.00354609929078014	282	8202	3339	HSPG2
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.849761034744702	-0.162800104618263	54	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.849761034744702	-0.162800104618263	54	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-5663205	Infectious disease	0.850569573672066	-0.161849067232588	347	9	0.0319148936170213	282	8202	118429,6165,2534,3840,902,5062,22916,84168,6857	ANTXR2,RPL35A,FYN,KPNA4,CCNH,PAK2,NCBP2,ANTXR1,SYT1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.854960763297979	-0.156699701977952	55	1	0.00354609929078014	282	8202	1974	EIF4A2
R-HSA-72649	Translation initiation complex formation	0.854960763297979	-0.156699701977952	55	1	0.00354609929078014	282	8202	1974	EIF4A2
R-HSA-391251	Protein folding	0.854960763297979	-0.156699701977952	55	1	0.00354609929078014	282	8202	7277	TUBA4A
R-HSA-977443	GABA receptor activation	0.854960763297979	-0.156699701977952	55	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-2187338	Visual phototransduction	0.856037279117329	-0.155441353417973	98	2	0.00709219858156028	282	8202	3339,2792	HSPG2,GNGT1
R-HSA-69239	Synthesis of DNA	0.856037279117329	-0.155441353417973	98	2	0.00709219858156028	282	8202	5984,4171	RFC4,MCM2
R-HSA-156580	Phase II conjugation	0.856037279117329	-0.155441353417973	98	2	0.00709219858156028	282	8202	6820,4144	SULT2B1,MAT2A
R-HSA-380108	Chemokine receptors bind chemokines	0.85998114684865	-0.150844812243892	56	1	0.00354609929078014	282	8202	58191	CXCL16
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.85998114684865	-0.150844812243892	56	1	0.00354609929078014	282	8202	1974	EIF4A2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.871030529100495	-0.138078252111867	102	2	0.00709219858156028	282	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-2132295	MHC class II antigen presentation	0.871030529100495	-0.138078252111867	102	2	0.00709219858156028	282	8202	6712,7879	SPTBN2,RAB7A
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.874026824583348	-0.134644212054623	59	1	0.00354609929078014	282	8202	2736	GLI2
R-HSA-446203	Asparagine N-linked glycosylation	0.874887471074763	-0.133660005380773	181	4	0.0141843971631206	282	8202	10195,6184,6480,4249	ALG3,RPN1,ST6GAL1,MGAT5
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.877977919607708	-0.130133834173833	104	2	0.00709219858156028	282	8202	6165,1974	RPL35A,EIF4A2
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.881321017231601	-0.126333341173134	105	2	0.00709219858156028	282	8202	6165,1974	RPL35A,EIF4A2
R-HSA-73886	Chromosome Maintenance	0.881321017231601	-0.126333341173134	105	2	0.00709219858156028	282	8202	5984,8607	RFC4,RUVBL1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.881321017231601	-0.126333341173134	105	2	0.00709219858156028	282	8202	6196,1021	RPS6KA2,CDK6
R-HSA-421270	Cell-cell junction organization	0.88260140855851	-0.124881586228509	61	1	0.00354609929078014	282	8202	5584	PRKCI
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.884579541710948	-0.122642840979096	106	2	0.00709219858156028	282	8202	6165,22916	RPL35A,NCBP2
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.884579541710948	-0.122642840979096	106	2	0.00709219858156028	282	8202	6165,22916	RPL35A,NCBP2
R-HSA-69306	DNA Replication	0.884579541710948	-0.122642840979096	106	2	0.00709219858156028	282	8202	5984,4171	RFC4,MCM2
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.886668034613963	-0.12028462307799	62	1	0.00354609929078014	282	8202	60412	EXOC4
R-HSA-73857	RNA Polymerase II Transcription	0.88775533047461	-0.119059102699794	107	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-68877	Mitotic Prometaphase	0.890850195032684	-0.115578996923424	108	2	0.00709219858156028	282	8202	10274,10051	STAG1,SMC4
R-HSA-69206	G1/S Transition	0.893865920714457	-0.112199491885739	109	2	0.00709219858156028	282	8202	902,4171	CCNH,MCM2
R-HSA-5358346	Hedgehog ligand biogenesis	0.894384965675204	-0.111618986119716	64	1	0.00354609929078014	282	8202	55733	HHAT
R-HSA-3214841	PKMTs methylate histone lysines	0.894384965675204	-0.111618986119716	64	1	0.00354609929078014	282	8202	2122	MECOM
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.894384965675204	-0.111618986119716	64	1	0.00354609929078014	282	8202	5585	PKN1
R-HSA-1236974	ER-Phagosome pathway	0.894384965675204	-0.111618986119716	64	1	0.00354609929078014	282	8202	29927	SEC61A1
R-HSA-69202	Cyclin E associated events during G1/S transition	0.898044764113674	-0.107535363243417	65	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-397014	Muscle contraction	0.898044764113674	-0.107535363243417	65	1	0.00354609929078014	282	8202	7273	TTN
R-HSA-201681	TCF dependent signaling in response to WNT	0.900238783668156	-0.105095235660837	229	5	0.0177304964539007	282	8202	857,8607,6259,59352,22943	CAV1,RUVBL1,RYK,LGR6,DKK1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.901578176485583	-0.103608521867201	66	1	0.00354609929078014	282	8202	170506	DHX36
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.901578176485583	-0.103608521867201	66	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-69278	Cell Cycle, Mitotic	0.902575133056558	-0.10250334231602	477	12	0.0425531914893617	282	8202	5984,902,80321,10274,5577,80254,4171,7029,1021,23175,10051,7277	RFC4,CCNH,CEP70,STAG1,PRKAR2B,CEP63,MCM2,TFDP2,CDK6,LPIN1,SMC4,TUBA4A
R-HSA-68867	Assembly of the pre-replicative complex	0.904989552388511	-0.099831879670935	67	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-913531	Interferon Signaling	0.90599750847621	-0.0987187229691976	194	4	0.0141843971631206	282	8202	3840,1958,1974,3669	KPNA4,EGR1,EIF4A2,ISG20
R-HSA-5663220	RHO GTPases Activate Formins	0.907818075565105	-0.096711277762204	114	2	0.00709219858156028	282	8202	5217,114793	PFN2,FMNL2
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.908283092176953	-0.0961991734474551	68	1	0.00354609929078014	282	8202	545	ATR
R-HSA-202403	TCR signaling	0.910394953055416	-0.0938767592816146	115	2	0.00709219858156028	282	8202	5291,5062	PIK3CB,PAK2
R-HSA-1500620	Meiosis	0.910394953055416	-0.0938767592816146	115	2	0.00709219858156028	282	8202	545,10274	ATR,STAG1
R-HSA-2262752	Cellular responses to stress	0.910787838026876	-0.0934452979483766	379	9	0.0319148936170213	282	8202	5599,6196,80012,30849,9140,545,7422,2113,1021	MAPK8,RPS6KA2,PHC3,PIK3R4,ATG12,ATR,VEGFA,ETS1,CDK6
R-HSA-68949	Orc1 removal from chromatin	0.914532749614396	-0.089342000295007	70	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.914532749614396	-0.089342000295007	70	1	0.00354609929078014	282	8202	8607	RUVBL1
R-HSA-69052	Switching of origins to a post-replicative state	0.914532749614396	-0.089342000295007	70	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-774815	Nucleosome assembly	0.914532749614396	-0.089342000295007	70	1	0.00354609929078014	282	8202	8607	RUVBL1
R-HSA-2299718	Condensation of Prophase Chromosomes	0.917496567202955	-0.0861064405285803	71	1	0.00354609929078014	282	8202	10051	SMC4
R-HSA-69300	Removal of licensing factors from origins	0.920357957919359	-0.082992599917917	72	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-3214858	RMTs methylate histone arginines	0.92836224395022	-0.0743332732780308	75	1	0.00354609929078014	282	8202	86	ACTL6A
R-HSA-69304	Regulation of DNA replication	0.92836224395022	-0.0743332732780308	75	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-1630316	Glycosaminoglycan metabolism	0.928711785140982	-0.0739568303474706	123	2	0.00709219858156028	282	8202	3339,10057	HSPG2,ABCC5
R-HSA-428157	Sphingolipid metabolism	0.930848013274265	-0.0716592660800237	76	1	0.00354609929078014	282	8202	259230	SGMS1
R-HSA-162599	Late Phase of HIV Life Cycle	0.936488938209608	-0.0656175690101379	127	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-162909	Host Interactions of HIV factors	0.936488938209608	-0.0656175690101379	127	2	0.00709219858156028	282	8202	2534,5062	FYN,PAK2
R-HSA-1236975	Antigen processing-Cross presentation	0.942045218123724	-0.0597020033033616	81	1	0.00354609929078014	282	8202	29927	SEC61A1
R-HSA-68874	M/G1 Transition	0.944057685621052	-0.0575680070542128	82	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-69002	DNA Replication Pre-Initiation	0.944057685621052	-0.0575680070542128	82	1	0.00354609929078014	282	8202	4171	MCM2
R-HSA-192823	Viral mRNA Translation	0.947876092568575	-0.0535314893112205	84	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-156902	Peptide chain elongation	0.947876092568575	-0.0535314893112205	84	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-5632684	Hedgehog 'on' state	0.947876092568575	-0.0535314893112205	84	1	0.00354609929078014	282	8202	2736	GLI2
R-HSA-351202	Metabolism of polyamines	0.947876092568575	-0.0535314893112205	84	1	0.00354609929078014	282	8202	384	ARG2
R-HSA-162906	HIV Infection	0.949670375296028	-0.051640327969341	221	4	0.0141843971631206	282	8202	22916,2534,902,5062	NCBP2,FYN,CCNH,PAK2
R-HSA-72764	Eukaryotic Translation Termination	0.949686753053566	-0.0516230823894615	85	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-68875	Mitotic Prophase	0.951154615289667	-0.0500786478539773	136	2	0.00709219858156028	282	8202	23175,10051	LPIN1,SMC4
R-HSA-3371556	Cellular response to heat stress	0.951434730837391	-0.0497841906708574	86	1	0.00354609929078014	282	8202	545	ATR
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.953122188448723	-0.0480121690150015	87	1	0.00354609929078014	282	8202	8607	RUVBL1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.953122188448723	-0.0480121690150015	87	1	0.00354609929078014	282	8202	54464	XRN1
R-HSA-5687128	MAPK6/MAPK4 signaling	0.954751214059775	-0.0463044812776606	88	1	0.00354609929078014	282	8202	5062	PAK2
R-HSA-156842	Eukaryotic Translation Elongation	0.954751214059775	-0.0463044812776606	88	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-73777	RNA Polymerase I Chain Elongation	0.954751214059775	-0.0463044812776606	88	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-162587	HIV Life Cycle	0.956582279123352	-0.0443884727628987	140	2	0.00709219858156028	282	8202	22916,902	NCBP2,CCNH
R-HSA-5625740	RHO GTPases activate PKNs	0.957841965519271	-0.0430724775426724	90	1	0.00354609929078014	282	8202	5585	PKN1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.960270112664712	-0.0405406667375526	143	2	0.00709219858156028	282	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-71387	Metabolism of carbohydrates	0.962462754454286	-0.0382599102398048	274	5	0.0177304964539007	282	8202	2992,5106,3339,10057,3099	GYG1,PCK2,HSPG2,ABCC5,HK2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.962560209207134	-0.0381586597562821	145	2	0.00709219858156028	282	8202	902,4774	CCNH,NFIA
R-HSA-72689	Formation of a pool of free 40S subunits	0.963406490501087	-0.0372798477305637	94	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-168254	Influenza Infection	0.964723638705288	-0.0359136034204575	147	2	0.00709219858156028	282	8202	6165,3840	RPL35A,KPNA4
R-HSA-202424	Downstream TCR signaling	0.965907854040577	-0.0346868385114065	96	1	0.00354609929078014	282	8202	5291	PIK3CB
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.970410902503585	-0.0300356863540072	100	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-212436	Generic Transcription Pathway	0.971942818445236	-0.0284583050122221	553	12	0.0425531914893617	282	8202	6498,9668,83667,1490,79718,3164,169841,25937,6907,7029,54541,7182	SKIL,ZNF432,SESN2,CTGF,TBL1XR1,NR4A1,ZNF169,WWTR1,TBL1X,TFDP2,DDIT4,NR2C2
R-HSA-427413	NoRC negatively regulates rRNA expression	0.974320996045452	-0.0260144649057383	104	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.976911660333387	-0.0233590503381866	107	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.976911660333387	-0.0233590503381866	107	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-73864	RNA Polymerase I Transcription	0.978492362460491	-0.0217422975311014	109	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-199991	Membrane Trafficking	0.978752798974811	-0.0214761719368337	256	4	0.0141843971631206	282	8202	152503,7037,9276,60412	SH3D19,TFRC,COPB2,EXOC4
R-HSA-372790	Signaling by GPCR	0.980585206207235	-0.0196057363490946	1230	31	0.109929078014184	282	8202	6712,200734,1604,2247,5922,2792,1894,1852,84033,9542,283455,5577,23236,5140,5291,9965,29,50940,3363,8660,58191,2534,6196,23263,2863,797,5144,1608,11343,5330,3269	SPTBN2,SPRED2,CD55,FGF2,RASA2,GNGT1,ECT2,DUSP9,OBSCN,NRG2,KSR2,PRKAR2B,PLCB1,PDE3B,PIK3CB,FGF19,ABR,PDE11A,HTR7,IRS2,CXCL16,FYN,RPS6KA2,MCF2L,GPR39,CALCB,PDE4D,DGKG,MGLL,PLCB2,HRH1
R-HSA-72163	mRNA Splicing - Major Pathway	0.9813375150453	-0.0188388265551579	113	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.983966262531576	-0.0161636685628103	267	4	0.0141843971631206	282	8202	7328,29927,92369,79876	UBE2H,SEC61A1,SPSB4,UBA5
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.984510343824604	-0.0156108742800363	223	3	0.0106382978723404	282	8202	7328,92369,79876	UBE2H,SPSB4,UBA5
R-HSA-72172	mRNA Splicing	0.985443595022608	-0.0146633889105389	120	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-212165	Epigenetic regulation of gene expression	0.987371682389396	-0.0127087325341938	124	1	0.00354609929078014	282	8202	902	CCNH
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.988648752169119	-0.011416164972451	127	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-195258	RHO GTPase Effectors	0.989981451433376	-0.010069071954904	285	4	0.0141843971631206	282	8202	5585,5217,114793,5062	PKN1,PFN2,FMNL2,PAK2
R-HSA-168255	Influenza Life Cycle	0.991757996419847	-0.00827615668110819	136	1	0.00354609929078014	282	8202	6165	RPL35A
R-HSA-5653656	Vesicle-mediated transport	0.992113542905195	-0.00791771967336138	294	4	0.0141843971631206	282	8202	152503,7037,9276,60412	SH3D19,TFRC,COPB2,EXOC4
R-HSA-500792	GPCR ligand binding	0.995115952943478	-0.00489601299170673	444	7	0.024822695035461	282	8202	3363,2863,58191,797,1604,2792,3269	HTR7,GPR39,CXCL16,CALCB,CD55,GNGT1,HRH1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.995501937261679	-0.00450820946101621	153	1	0.00354609929078014	282	8202	22916	NCBP2
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.995885218165803	-0.00412327084391984	318	4	0.0141843971631206	282	8202	3363,2863,58191,3269	HTR7,GPR39,CXCL16,HRH1
R-HSA-2467813	Separation of Sister Chromatids	0.996618871763067	-0.00338685716815606	161	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-68882	Mitotic Anaphase	0.997717524262794	-0.00228508455541643	172	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-418594	G alpha (i) signalling events	0.997783166274248	-0.00221929453911743	236	2	0.00709219858156028	282	8202	58191,2792	CXCL16,GNGT1
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.99779768093716	-0.0022047477339283	173	1	0.00354609929078014	282	8202	10274	STAG1
R-HSA-68886	M Phase	0.998129347208375	-0.00187240464764233	296	3	0.0106382978723404	282	8202	10274,23175,10051	STAG1,LPIN1,SMC4
R-HSA-375276	Peptide ligand-binding receptors	0.998923664983295	-0.00107691468121821	193	1	0.00354609929078014	282	8202	58191	CXCL16
R-HSA-388396	GPCR downstream signaling	0.999262430688736	-0.000737841449330547	928	17	0.0602836879432624	282	8202	2792,1894,84033,23236,5140,5291,29,50940,3363,58191,23263,5144,797,5330,11343,1608,3269	GNGT1,ECT2,OBSCN,PLCB1,PDE3B,PIK3CB,ABR,PDE11A,HTR7,CXCL16,MCF2L,PDE4D,CALCB,PLCB2,MGLL,DGKG,HRH1
R-HSA-74160	Gene Expression	0.999908462555583	-9.15416342248883e-05	1330	25	0.0886524822695035	282	8202	833,83667,8893,902,79718,3164,169841,1974,4774,10644,54541,6498,58477,9668,6165,6184,29927,1490,25937,6747,22916,54464,6907,7029,7182	CARS,SESN2,EIF2B5,CCNH,TBL1XR1,NR4A1,ZNF169,EIF4A2,NFIA,IGF2BP2,DDIT4,SKIL,SRPRB,ZNF432,RPL35A,RPN1,SEC61A1,CTGF,WWTR1,SSR3,NCBP2,XRN1,TBL1X,TFDP2,NR2C2
R-HSA-381753	Olfactory Signaling Pathway	0.999998825305921	-1.17469476895725e-06	381	1	0.00354609929078014	282	8202	2792	GNGT1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-69618	Mitotic Spindle Checkpoint	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-190861	Gap junction assembly	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-1181150	Signaling by NODAL	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-1643713	Signaling by EGFR in Cancer	0.999999999976386	-2.36144517589533e-11	19	0	0	282	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5653890	Lactose synthesis	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-70350	Fructose catabolism	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-111458	Formation of apoptosome	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-193681	Ceramide signalling	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1296067	Potassium transport channels	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-351200	Interconversion of polyamines	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-73927	Depurination	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999978224	-2.17763842778906e-11	3	0	0	282	8202
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.99999999998055	-1.94495965909532e-11	36	0	0	282	8202
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.99999999998055	-1.94495965909532e-11	36	0	0	282	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-68952	DNA replication initiation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-70921	Histidine catabolism	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-176417	Phosphorylation of Emi1	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-205025	NADE modulates death signalling	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-211916	Vitamins	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-73942	DNA Damage Reversal	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-189483	Heme degradation	0.999999999983164	-1.68362113812053e-11	6	0	0	282	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999983377	-1.66229510462945e-11	22	0	0	282	8202
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.999999999983377	-1.66229510462945e-11	22	0	0	282	8202
R-HSA-3371571	HSF1-dependent transactivation	0.999999999983377	-1.66229510462945e-11	22	0	0	282	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999983377	-1.66229510462945e-11	22	0	0	282	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999983377	-1.66229510462945e-11	22	0	0	282	8202
R-HSA-166663	Initial triggering of complement	0.999999999983916	-1.60842242960129e-11	20	0	0	282	8202
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999983916	-1.60842242960129e-11	20	0	0	282	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-209776	Amine-derived hormones	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-5635838	Activation of SMO	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999985305	-1.46952366009748e-11	18	0	0	282	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-5218859	Regulated Necrosis	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-392517	Rap1 signalling	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-5625900	RHO GTPases activate CIT	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-69183	Processive synthesis on the lagging strand	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-1369062	ABC transporters in lipid homeostasis	0.999999999985969	-1.40314469298897e-11	16	0	0	282	8202
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999986073	-1.3927252578512e-11	41	0	0	282	8202
R-HSA-75893	TNF signaling	0.999999999986073	-1.3927252578512e-11	41	0	0	282	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-70268	Pyruvate metabolism	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-5260271	Diseases of Immune System	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-933542	TRAF6 mediated NF-kB activation	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-5365859	RA biosynthesis pathway	0.999999999986144	-1.38555322688876e-11	24	0	0	282	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-389542	NADPH regeneration	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-3248023	Regulation by TREX1	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-169131	Inhibition of PKR	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1483076	Synthesis of CL	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1300645	Acrosome Reaction	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5619084	ABC transporter disorders	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999987465	-1.25352922486499e-11	1	0	0	282	8202
R-HSA-1268020	Mitochondrial protein import	0.999999999988272	-1.1727514259691e-11	52	0	0	282	8202
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.999999999988272	-1.1727514259691e-11	52	0	0	282	8202
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.999999999988272	-1.1727514259691e-11	52	0	0	282	8202
R-HSA-69541	Stabilization of p53	0.999999999988272	-1.1727514259691e-11	52	0	0	282	8202
R-HSA-69610	p53-Independent DNA Damage Response	0.999999999988272	-1.1727514259691e-11	52	0	0	282	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-71262	Carnitine synthesis	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-173736	Alternative complement activation	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-1296061	HCN channels	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-75072	mRNA Editing	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-1296053	Classical Kir channels	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-6783984	Glycine degradation	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-888593	Reuptake of GABA	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-209563	Axonal growth stimulation	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-428776	Class II GLUTs	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-442745	Activation of CaMK IV	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-167060	NGF processing	0.999999999988525	-1.14752502271001e-11	4	0	0	282	8202
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.99999999998964	-1.03601191860377e-11	27	0	0	282	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.99999999998964	-1.03601191860377e-11	27	0	0	282	8202
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-916853	Degradation of GABA	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-168268	Virus Assembly and Release	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-1483101	Synthesis of PS	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-192905	vRNP Assembly	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5652227	Fructose biosynthesis	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-75102	C6 deamination of adenosine	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-844623	The IPAF inflammasome	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-156582	Acetylation	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-198765	Signalling to ERK5	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-351143	Agmatine biosynthesis	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-70688	Proline catabolism	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-75094	Formation of the Editosome	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-111995	phospho-PLA2 pathway	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-1483226	Synthesis of PI	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-5662702	Melanin biosynthesis	0.99999999999013	-9.87025196817759e-12	2	0	0	282	8202
R-HSA-389948	PD-1 signaling	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-1482839	Acyl chain remodelling of PE	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-211976	Endogenous sterols	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-191273	Cholesterol biosynthesis	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-201451	Signaling by BMP	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999990213	-9.78724663850732e-12	23	0	0	282	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-156587	Amino Acid conjugation	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-162592	Integration of provirus	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-425381	Bicarbonate transporters	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-390696	Adrenoceptors	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1462054	Alpha-defensins	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999990913	-9.08704686973959e-12	9	0	0	282	8202
R-HSA-1660662	Glycosphingolipid metabolism	0.999999999991325	-8.67483302154639e-12	40	0	0	282	8202
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.999999999991325	-8.67483302154639e-12	40	0	0	282	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-75157	FasL/ CD95L signaling	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-5652084	Fructose metabolism	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2161541	Abacavir metabolism	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-446205	Synthesis of GDP-mannose	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-167827	The proton buffering model	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2161517	Abacavir transmembrane transport	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-444209	Free fatty acid receptors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-70370	Galactose catabolism	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-197264	Nicotinamide salvaging	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-114516	Disinhibition of SNARE formation	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-390651	Dopamine receptors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-157881	Cyclin B2 mediated events	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111463	SMAC binds to IAPs	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-561048	Organic anion transport	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-391906	Leukotriene receptors	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-68911	G2 Phase	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-1169092	Activation of RAS in B cells	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-112307	Transmission across Electrical Synapses	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-167826	The fatty acid cycling model	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999991699	-8.30119448626471e-12	5	0	0	282	8202
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-211935	Fatty acids	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-159418	Recycling of bile acids and salts	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-194223	HDL-mediated lipid transport	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5358508	Mismatch Repair	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.999999999993469	-6.53122773916863e-12	15	0	0	282	8202
R-HSA-167287	HIV elongation arrest and recovery	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-2129379	Molecules associated with elastic fibres	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-168638	NOD1/2 Signaling Pathway	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-418990	Adherens junctions interactions	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-5357905	Regulation of TNFR1 signaling	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-180746	Nuclear import of Rev protein	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.999999999993669	-6.33065654382705e-12	31	0	0	282	8202
R-HSA-74259	Purine catabolism	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-419771	Opsins	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-190873	Gap junction degradation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-2161522	Abacavir transport and metabolism	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999994312	-5.68844863501812e-12	10	0	0	282	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-162594	Early Phase of HIV Life Cycle	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-3371568	Attenuation phase	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-2024101	CS/DS degradation	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-69166	Removal of the Flap Intermediate	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5682910	LGI-ADAM interactions	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-5675482	Regulation of necroptotic cell death	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-877312	Regulation of IFNG signaling	0.99999999999461	-5.39019021396097e-12	14	0	0	282	8202
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999994721	-5.27859826438577e-12	33	0	0	282	8202
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.999999999994721	-5.27859826438577e-12	33	0	0	282	8202
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.999999999994721	-5.27859826438577e-12	33	0	0	282	8202
R-HSA-5694530	Cargo concentration in the ER	0.999999999994721	-5.27859826438577e-12	33	0	0	282	8202
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.999999999994845	-5.15478827957068e-12	42	0	0	282	8202
R-HSA-1461957	Beta defensins	0.999999999994845	-5.15478827957068e-12	42	0	0	282	8202
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.999999999995157	-4.843055198152e-12	72	0	0	282	8202
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999995522	-4.4777557429877e-12	32	0	0	282	8202
R-HSA-1980145	Signaling by NOTCH2	0.999999999995522	-4.4777557429877e-12	32	0	0	282	8202
R-HSA-186712	Regulation of beta-cell development	0.999999999995522	-4.4777557429877e-12	32	0	0	282	8202
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.999999999995833	-4.16738275953473e-12	37	0	0	282	8202
R-HSA-156590	Glutathione conjugation	0.999999999995833	-4.16738275953473e-12	37	0	0	282	8202
R-HSA-879518	Transport of organic anions	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-71288	Creatine metabolism	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1980148	Signaling by NOTCH3	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-71064	Lysine catabolism	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1059683	Interleukin-6 signaling	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-211999	CYP2E1 reactions	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-193048	Androgen biosynthesis	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-71240	Tryptophan catabolism	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5655291	Signaling by FGFR4 in disease	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-189451	Heme biosynthesis	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-1980150	Signaling by NOTCH4	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999996015	-3.98545497660672e-12	11	0	0	282	8202
R-HSA-5362517	Signaling by Retinoic Acid	0.99999999999721	-2.79020063216976e-12	44	0	0	282	8202
R-HSA-446652	Interleukin-1 signaling	0.99999999999721	-2.79020063216976e-12	44	0	0	282	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-174577	Activation of C3 and C5	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-447043	Neurofascin interactions	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-111471	Apoptotic factor-mediated response	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-75158	TRAIL  signaling	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-196791	Vitamin D (calciferol) metabolism	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-166665	Terminal pathway of complement	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-190371	FGFR3b ligand binding and activation	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-429593	Inositol transporters	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-5619102	SLC transporter disorders	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-427601	Multifunctional anion exchangers	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-164843	2-LTR circle formation	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-2142789	Ubiquinol biosynthesis	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.999999999997389	-2.61065442665018e-12	7	0	0	282	8202
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.999999999998391	-1.6091216788139e-12	38	0	0	282	8202
R-HSA-1461973	Defensins	0.999999999998585	-1.41456323507075e-12	51	0	0	282	8202
R-HSA-180534	Vpu mediated degradation of CD4	0.999999999998585	-1.41456323507075e-12	51	0	0	282	8202
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.999999999998585	-1.41456323507075e-12	51	0	0	282	8202
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.999999999998598	-1.40187898627752e-12	59	0	0	282	8202
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.999999999998598	-1.40187898627752e-12	59	0	0	282	8202
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.999999999998598	-1.40187898627752e-12	59	0	0	282	8202
R-HSA-5334118	DNA methylation	0.999999999999652	-3.48544365002941e-13	62	0	0	282	8202
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-912694	Regulation of IFNA signaling	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-983189	Kinesins	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-77387	Insulin receptor recycling	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000022	2.1646474932632e-13	26	0	0	282	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-196836	Vitamin C (ascorbate) metabolism	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-428643	Organic anion transporters	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-1483115	Hydrolysis of LPC	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-73928	Depyrimidination	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-804914	Transport of fatty acids	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-196783	Coenzyme A biosynthesis	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-444821	Relaxin receptors	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-177128	Conjugation of salicylate with glycine	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-5632681	Ligand-receptor interactions	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-2046105	Linoleic acid (LA) metabolism	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-192456	Digestion of dietary lipid	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	1.00000000000135	1.35034666236277e-12	8	0	0	282	8202
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	1.00000000000145	1.44655004471418e-12	49	0	0	282	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000000145	1.44655004471418e-12	49	0	0	282	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000000171	1.70737668212368e-12	39	0	0	282	8202
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000000171	1.70737668212368e-12	39	0	0	282	8202
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	1.00000000000171	1.70737668212368e-12	39	0	0	282	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000000171	1.70737668212368e-12	39	0	0	282	8202
R-HSA-165159	mTOR signalling	1.00000000000171	1.70737668212368e-12	39	0	0	282	8202
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	1.00000000000236	2.35927148918262e-12	66	0	0	282	8202
R-HSA-1169091	Activation of NF-kappaB in B cells	1.00000000000236	2.35927148918262e-12	66	0	0	282	8202
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1.00000000000254	2.54355092809992e-12	53	0	0	282	8202
R-HSA-5673000	RAF activation	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-162588	Budding and maturation of HIV virion	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.00000000000302	3.0247315617172e-12	25	0	0	282	8202
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	1.00000000000317	3.16522683526653e-12	57	0	0	282	8202
R-HSA-69563	p53-Dependent G1 DNA Damage Response	1.00000000000317	3.16522683526653e-12	57	0	0	282	8202
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000000328	3.28271117831688e-12	54	0	0	282	8202
R-HSA-4641257	Degradation of AXIN	1.00000000000328	3.28271117831688e-12	54	0	0	282	8202
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000000334	3.33599053790696e-12	73	0	0	282	8202
R-HSA-177243	Interactions of Rev with host cellular proteins	1.00000000000341	3.41151231755974e-12	34	0	0	282	8202
R-HSA-176033	Interactions of Vpr with host cellular proteins	1.00000000000341	3.41151231755974e-12	34	0	0	282	8202
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-2871809	FCERI mediated Ca+2 mobilization	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-5683826	Surfactant metabolism	1.00000000000358	3.58269045385468e-12	30	0	0	282	8202
R-HSA-2022854	Keratan sulfate biosynthesis	1.0000000000042	4.20425686905931e-12	28	0	0	282	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.0000000000042	4.20425686905931e-12	28	0	0	282	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.0000000000042	4.20425686905931e-12	28	0	0	282	8202
R-HSA-190828	Gap junction trafficking	1.0000000000042	4.20425686905931e-12	28	0	0	282	8202
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.0000000000042	4.20425686905931e-12	28	0	0	282	8202
R-HSA-432720	Lysosome Vesicle Biogenesis	1.00000000000438	4.38018412223911e-12	35	0	0	282	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.00000000000438	4.38018412223911e-12	35	0	0	282	8202
R-HSA-4608870	Asymmetric localization of PCP proteins	1.00000000000457	4.56672945444443e-12	63	0	0	282	8202
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-176412	Phosphorylation of the APC/C	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-622312	Inflammasomes	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-69205	G1/S-Specific Transcription	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-1482801	Acyl chain remodelling of PS	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-189445	Metabolism of porphyrins	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000479	4.78921920590469e-12	17	0	0	282	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000000517	5.16553228519147e-12	48	0	0	282	8202
R-HSA-73887	Death Receptor Signalling	1.00000000000517	5.16553228519147e-12	48	0	0	282	8202
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000000628	6.27968143835069e-12	45	0	0	282	8202
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.00000000000672	6.72231743272562e-12	77	0	0	282	8202
R-HSA-2871837	FCERI mediated NF-kB activation	1.00000000000672	6.72231743272562e-12	77	0	0	282	8202
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	1.00000000000672	6.72231743272562e-12	77	0	0	282	8202
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1.00000000000802	8.02026619275493e-12	69	0	0	282	8202
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1.00000000000802	8.02026619275493e-12	69	0	0	282	8202
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.0000000000081	8.10390302020153e-12	64	0	0	282	8202
R-HSA-5578749	Transcriptional regulation by small RNAs	1.00000000000868	8.67781036430946e-12	101	0	0	282	8202
R-HSA-211000	Gene Silencing by RNA	1.00000000000887	8.87327162279792e-12	130	0	0	282	8202
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	1.00000000000898	8.98371856531259e-12	61	0	0	282	8202
R-HSA-211897	Cytochrome P450 - arranged by substrate type	1.00000000000898	8.98371856531259e-12	61	0	0	282	8202
R-HSA-453276	Regulation of mitotic cell cycle	1.00000000000942	9.42058202481623e-12	83	0	0	282	8202
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	1.00000000000942	9.42058202481623e-12	83	0	0	282	8202
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	1.00000000000992	9.91809304010106e-12	46	0	0	282	8202
R-HSA-6784531	tRNA processing in the nucleus	1.00000000001003	1.00269234618041e-11	55	0	0	282	8202
R-HSA-5387390	Hh mutants abrogate ligand secretion	1.00000000001003	1.00269234618041e-11	55	0	0	282	8202
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1.00000000001003	1.00269234618041e-11	55	0	0	282	8202
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.00000000001003	1.00269234618041e-11	55	0	0	282	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000001014	1.01382534663835e-11	65	0	0	282	8202
R-HSA-5607764	CLEC7A (Dectin-1) signaling	1.00000000001046	1.04557228574903e-11	99	0	0	282	8202
R-HSA-199977	ER to Golgi Anterograde Transport	1.00000000001048	1.04771275177154e-11	68	0	0	282	8202
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1.00000000001077	1.0772673072144e-11	47	0	0	282	8202
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000001165	1.16532762943986e-11	70	0	0	282	8202
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1.00000000001165	1.16532762943986e-11	70	0	0	282	8202
R-HSA-69615	G1/S DNA Damage Checkpoints	1.00000000001175	1.17531785920981e-11	60	0	0	282	8202
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1.00000000001175	1.17531785920981e-11	60	0	0	282	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000001175	1.17531785920981e-11	60	0	0	282	8202
R-HSA-912446	Meiotic recombination	1.00000000001225	1.22495498542759e-11	84	0	0	282	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-211981	Xenobiotics	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-2022870	Chondroitin sulfate biosynthesis	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-156588	Glucuronidation	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	1.00000000001316	1.31562548635906e-11	21	0	0	282	8202
R-HSA-195253	Degradation of beta-catenin by the destruction complex	1.00000000001345	1.34476628658603e-11	81	0	0	282	8202
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	1.000000000014	1.40039985265472e-11	56	0	0	282	8202
R-HSA-4641258	Degradation of DVL	1.000000000014	1.40039985265472e-11	56	0	0	282	8202
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-445355	Smooth Muscle Contraction	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-3299685	Detoxification of Reactive Oxygen Species	1.00000000001528	1.52799024337933e-11	29	0	0	282	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-2160916	Hyaluronan uptake and degradation	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-3371511	HSF1 activation	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-211958	Miscellaneous substrates	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-417957	P2Y receptors	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-202670	ERKs are inactivated	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-211979	Eicosanoids	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000001597	1.59671465537816e-11	12	0	0	282	8202
R-HSA-72306	tRNA processing	1.00000000001661	1.66111300447044e-11	94	0	0	282	8202
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.00000000001745	1.74486936606014e-11	50	0	0	282	8202
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.00000000001745	1.74486936606014e-11	50	0	0	282	8202
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.00000000001745	1.74486936606014e-11	50	0	0	282	8202
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.00000000001745	1.74486936606014e-11	50	0	0	282	8202
R-HSA-1502540	Signaling by Activin	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-209560	NF-kB is activated and signals survival	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-211227	Activation of DNA fragmentation factor	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-350054	Notch-HLH transcription pathway	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-75205	Dissolution of Fibrin Clot	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-174403	Glutathione synthesis and recycling	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-977441	GABA A receptor activation	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-171007	p38MAPK events	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-74217	Purine salvage	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-140342	Apoptosis induced DNA fragmentation	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-209822	Glycoprotein hormones	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-2995410	Nuclear Envelope Reassembly	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-5626467	RHO GTPases activate IQGAPs	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-4641265	Repression of WNT target genes	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-1663150	The activation of arylsulfatases	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-175474	Assembly Of The HIV Virion	1.00000000002055	2.05535481909012e-11	13	0	0	282	8202
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	1.0000000000211	2.11011410744458e-11	58	0	0	282	8202
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	1.0000000000211	2.11011410744458e-11	58	0	0	282	8202
R-HSA-877300	Interferon gamma signaling	1.00000000002267	2.2672347825525e-11	92	0	0	282	8202
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	1.00000000002303	2.30259823775359e-11	96	0	0	282	8202
